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Abstract
In hospitalized patients with neutropenia, Candida albicans is the fourth leading cause of
systemic bloodstream infections, which have a mortality rate of approximately 30 %. The
phosphatidylserine synthase enzyme of C. albicans, Cho1p, appears to be a good drug target
as a mutant lacking this enzyme (the cho1∆/∆ [null mutant]) is avirulent in animal models of
Candida infections and this enzyme is not conserved in humans. We discovered that the loss of
phosphatidylserine (PS) synthesis affects C. albicans' expression of the Als3p adhesin, a
virulence protein, and loss of PS synthesis also compromises the cell wall, causing increased
exposure of the polysaccharide β [beta]-(1,3) glucan that ultimately leads to increased
recognition by the immune system.
Downstream of phosphatidylserine synthase are the decarboxylase enzymes Psd1p and
Psd2p, which are essential for de novo synthesis of phosphatidylethanolamine from
phosphatidylserine. When these enzymes are lost, the only option the yeast has to acquiring
phosphatidylethanolamine is by synthesizing it by the Kennedy Pathway utilizing ethanolamine
acquired from the environment. The final chapter of my dissertation explores how ethanolamine
is difficult to acquire from the host in vivo, and is ultimately a bottleneck for C. albicans to cause
virulence in the mouse model of disseminated candidiasis.
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Chapter I: Background and Introduction
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An Overview of Candida albicans Virulence
Candida spp. are human commensal fungi that colonize the gastrointestinal tract, as well
as vaginal and oral mucosa (1). They occur as oral flora for approximately 30-60% of healthy
individuals and usually do not cause disease (2, 3). However, C. albicans and related species
are capable of causing more serious systemic infections, where it is present in the bloodstream
and deep organs, and are of great concern as they have a high associated mortality rate once
fungal septicemia is established (31.8%) (4). Systemic infections are a common problem in
intensive care units (ICUs), and are associated with risk factors such as major abdominal
surgery, catheterization and prolonged stays in the ICU (5). Patients with neutropenia are also
more susceptible to systemic fungal infections, making patients with leukemia or undergoing
vigorous chemotherapy treatments generally more susceptible to systemic infections (6, 7). In
addition, C. albicans is the leading blood-borne fungi to colonize patients’ prosthetic heart
valves (8). This affliction, which is known as fungal endocarditis, is extremely life threatening
with a mortality rate of up to 40%, and is difficult to treat with antifungals once established (9,
10).
Currently there are only five classes of antifungal drugs available to treat fungal
infections, and toxicity and resistance limit their effectiveness. Only 3 of the 5 can be used for
systemic infections, further limiting options for treatment of fungal bloodstream infections (1113). The polyenes bind ergosterol in the cell membrane, disrupting cell integrity and resulting in
cell death. An example is amphotericin B, which is the only polyene that is an effective
treatment for systemic infections, but must be given intravenously and has the ability to cause
kidney damage (14, 15). As ergosterol is a lipid that is unique to fungi, it has also been targeted
by the azole drug family, which inhibits the enzyme lanosterol 14 α-demethylase which converts
lanosterol to ergosterol. Ultimately inhibition of this pathway results in a lack of ergosterol in the
fungal cell membrane, and a fungistatic control of infection (16). Apart from targeting of
ergosterol, cell wall components that are unique to fungi can be targeted, in particular the
2

ß-(1,3) glucan saccharide that is important for cell wall infrastructure. Drugs that belong to the
echinocandins family (such as caspofungin) are able to inhibit the enzyme β-(1,3) glucan
synthase, thus causing the cell wall to eventually lose integrity (16). The remaining drugs are
hydrophobic and can only be used topically for fungal skin or nail infections. For example,
allylamines are hydrophobic and are not amenable for administration orally or intravenously
(17).
In immunocompromised patients Candida spp. are able to cause an extremely common
oral infection known as oropharyngeal Candidiasis (OPC) (2). OPC is one of the first indicators
of suppression of adaptive immunity, and is seen in up to 95% of AIDS patients at some time
during their infection (18). Other risk factors for OPC include use of steroid inhalers and the use
of dentures, and is becoming a common infection in recipients of solid organ transplants (1922). These infections are deleterious to the comfort of the patient causing difficulty chewing and
swallowing, and in severe cases will result in reduced eating and weight loss (2). It is important
to note that these oral infections are refractory to medications and often exhibit drug resistance,
making treatment challenging (23). Out of all Candida species, C. albicans is the species most
commonly isolated from oral lesions (24).
C. albicans morphology and its role in virulence
Morphology is also known to be involved in C. albicans virulence. Morphology
differences are dependent on the phenomenon known as "phenotypic switching", which is the
ability of C. albicans to switch between its 3 forms: yeast, pseudohyphae, and hyphae (Fig. 1.1).
In regards to virulence, the yeast form is regarded as being important for dispersion and travel
within the bloodstream, and the hyphal form important for tissue invasion and damage (Fig 1.1)
(25-28). This is at least partially due to differential gene regulation in the yeast or hyphal forms,
with the hyphal form expressing specific adhesins as well as secreted aspartyl proteases that
altogether enable it to become an effective bloodstream pathogen (29-31). Hyphal cells also
contain up to three times more chitin in comparison to yeast form, which may play a role in
3

immune resistance and robustness in surviving in vivo as it lends strength to the overall
structure of the cell (32). For instance, C. albicans strains that are upregulated in chitin
synthesis by upregulation of Pir32 are more virulent than wild type (33). Pir32 is also
upregulated when C. albicans is phagocytosed by macrophages, which may aid in C. albicans’
survival and escape of the macrophage phagosome (34).
The importance of hyphal formation of C. albicans for virulence is also demonstrated in
mutants that are unable to form hyphae. The efg1∆/∆ cph1∆/∆ double mutant is permanently
fixed in yeast-form and is less virulent, and is reduced in the ability to invade host endothelial
cells in the mouse oropharyngeal candidiasis model (25). However, there is evidence
suggesting that hyphal formation is not the end-all and be-all of C. albicans virulence. When the
hyper-filamentous C. albicans mutant tup1∆/∆ is generated, it is reduced in virulence and
dissemination (25). Altogether these findings suggest that both yeast and hyphal forms work
together in concert to disseminate in the bloodstream as well as invade host tissue.
A Phospholipid biosynthesis overview for fungi and humans
Apart from the morphology of Candida albicans, there are a variety of other components
that can contribute to virulence, such as secreted aspartyl proteases (SAPs), adhesin
molecules, and phospholipases (35). Inversely, many factors can contribute to a lack of
virulence for C. albicans including auxotrophy of essential nutrients such as amino acids (36,
37). As this dissertation is focused on how a loss of phospholipids can result in a loss of
virulence, and how yeast phospholipid synthesis enzymes could be unique drug targets, it is
vital to understand how yeast and mammals differ in the steps that it takes to generate these
various phospholipids. Yeast including C. albicans have two main means of synthesizing
phospholipids, either by the de novo process or via the Kennedy pathway (Fig. 1.2). The de
novo pathway is the sole means by which C. albicans can synthesize phosphatidylserine. It
does so from cytidine diphosphate diacylglycerol (CDP-DAG) and serine by the Cho1p enzyme
(38). Phosphatidylserine (PS) can then be decarboxylated into phosphatidylethanolamine (PE)
4

by the phosphatidylserine decarboxylases Psd1p (located in the mitochondria) or Psd2p
(located in the Golgi/vacuole) (39-42). Lastly, phosphatidylethanolamine can then be methylated
by the two methylases Opi3 and Cho2 to generate phosphatidylcholine (PC), the most abundant
phospholipid in yeast genera.
Apart from the de novo pathway, phosphatidylethanolamine and phosphatidylcholine can
be generated from the Kennedy pathway, which directly incorporates ethanolamine and choline
into diacylglycerol (DAG) to make their respective phospholipids (Fig.1.2) (41, 43). Synthesis of
PE or PC via the Kennedy pathway consists of a total of 3 enzymatic steps. First, ethanolamine
is phosphorylated in an ATP-dependent manner by an ethanolamine kinase. After
phosphorylation, the enzyme cytidine tri-phosphate (CTP) phosphoethanolamine
cytidylyltransferase uses the CTP as an energy source to generate (cytidine di-phosphate)
CDP-ethanolamine. Lastly, CDP-ethanolamine 1,2-diacylglycerol ethanolamine
phosphotransferase completes the final step of PE synthesis, using CDP-ethanolamine and
DAG to form PE. Synthesis of PC via the Kennedy pathway requires the same steps, but uses
choline as the head group substrate instead of ethanolamine. It has been found however that
generation of phosphatidylethanolamine via this pathway is limited by the supply of
ethanolamine in the media, and growth does not become as robust as wild type until exogenous
ethanolamine is supplied at 1 mM ethanolamine in minimal media (44).
Phospholipid synthesis and its role in virulence in organisms
Auxotrophy is known as the loss of an organism’s ability to synthesize an organic
compound required for growth, such as essential amino acids, fatty acids, or vitamins (45).
URA3 (synthesizes uracil), HIS3 (synthesizes histidine), and LYS4 (synthesizes lysine) are
three examples in which when knocked out in C. albicans, the yeast fails to grow in the absence
of these amino acids; as these amino acids are not readily available in the host, losses of these
genes also result in a reduction in virulence in an immune-competent mouse model of systemic
candidiasis (36, 46, 47). Auxotrophy in C. albicans for the synthesis of oleic acid also makes it
5

more susceptible to the antifungal drug amphotericin B, an important antifungal administered
intravenously (48). These fatty acids are important for the organism as they are essential for
synthesizing a variety of compounds within the cell, including phospholipids. Other fungal
pathogens may also be affected in virulence by auxotrophy. Aspergillus fumigatus, when it is
auxotrophic for uridine and uracil, is reduced in virulence in a mouse model of invasive
aspergillosis (37).
Phospholipid synthesis is an essential function for all living organisms, and when it is
disrupted there are repercussions, some which can be fatal, and others which have severe side
effects. For C. albicans, we have discovered that the loss of phosphatidylserine synthase in the
cho1∆/∆ mutant results in growth defects in minimal media, ethanolamine auxotrophy,
avirulence and cell wall defects (44). This mutant is also diminished in
phosphatidylethanolamine (PE) synthesis (a downstream product in the de novo pathway, Fig
1.2). In addition, the psd1∆/∆ psd2∆/∆ double mutant is comparably diminished in PE levels
(though not in PS, as the cho1∆/∆ mutant). We have discovered that for both of these mutants,
the loss of PE is responsible for both of them losing virulence in a mouse model of candidiasis,
as well as a diminished ability to colonize the oropharynges.
Interestingly, a role for phospholipids in virulence is not unique to C. albicans and
defects can occur in other organisms when phospholipid synthesis is compromised. One
example of phospholipid synthesis being important for virulence is exemplified by the bacterial
pathogen Brucella abortus, which is a facultatively intracellular bacterium that is responsible for
causing spontaneous abortions in cattle (a condition known as brucellosis) (49). When PE as
well as PS synthesis are diminished in a phosphatidylserine synthase mutant (pssA∆), there is
an increased sensitivity to detergents which indicates altered cell membrane properties (50).
This mutant was unable to successfully colonize a mouse and had difficulty surviving
intracellularly in an intro assay, suggesting that PE is essential for virulence (50). In addition,
Mycobacterium tuberculosis, which is a significant pathogen affecting hundreds of thousands
6

per year with lung infections (51) is diminished in virulence when it is no longer able to
synthesize inositol, a precursor for phosphatidylinositol (PI) synthesis (52). A loss of this
essential substrate resulted in a diminished ability to colonize macrophages as well as reduced
overall lethality in a pulmonary mouse model. PI is an important constituent for the virulence
factor lipoarabinomannan, which may explain how a loss of PI causes a reduction in virulence
(52, 53).
It has also been discovered that phospholipid synthesis is vital for virulence in a variety
of eukaryotes, including Plasmodium falciparum, a protozoan parasite that causes malaria in
humans and is one of the most significant pathogens even to this day (54, 55). It was revealed
that when phosphatidylcholine (PC) synthesis is inhibited in P. falciparum, it is unable to survive
in vitro in culture suggesting that it is vital for survival (56). This finding was determined by the
administration of the PC analog miltefosine, and then measuring the organism’s proliferation
rate in a blood culture (56). Yet another eukaryote that is influenced by the loss of lipid synthesis
is Toxoplasma gondii, another obligate intracellular protozoan that is responsible for causing
toxoplasmosis, a disease that affects an incredibly wide array of warm-blooded animals (57,
58). The T. gondii fatty acid synthesis II (FAS II) pathway is essential for lipoylation of the
apicoplast organelle. When this is abolished in the null mutant Acp∆, it is unable to survive in a
tissue culture plaque assays, and eliminating this enzyme from the pathogen eliminates all
mortality when injected in the mouse model (59), ultimately suggesting that synthesis of this
important lipid molecule is vital for the survival of this organism (59).
Ultimately the synthesis of phospholipids is vital for avirulence in several microbes.
Interestingly, despite studies in bacteria and parasites similar studies in pathogenic fungi are
largely lacking.
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Importance of adhesins in virulence for C. albicans
The Als family of adhesins expressed in C. albicans consists of 8 different proteins, that
are all GPI-anchored cell wall proteins that all generally play a role in adherence to surfaces as
well as inducing endocytosis by mammalian cells (60). Some of these Als proteins have been
implicated in virulence: for instance, the Als1p protein has been shown to greatly increase
adhesion to epithelial cells when artificially expressed in Saccharomyces cerevisiae (61).
Comparatively, addition of the Als3p protein to S. cerevisiae also increased adhesion to
epithelial cells to a statistically significant degree (61), and C. albicans that had Als3p removed
from the genome had a drastically lower level of adherence to epithelial cells (62).
The cell wall protein Als3p is a virulence factor that acts as an adhesin, invasin, and
binds host ferritin (31, 63-66), and it is specifically regulated by the transcription factor Rim101p
which mediates the pH mediated response (67, 68). There is also evidence that ALS1, ALS3,
and HWP1 are regulated by the Rlm1p transcription factor (69). The Als3p protein is produced
exclusively on the hyphal form of C. albicans (C. albicans morphology illustrated in Fig. 1.1)(70).
From an in vivo perspective, this pathway is implicated in virulence as it is activated when C.
albicans detects the pH neutral bloodstream as well as the presence of serum (67). While Als3p
does not appear to contribute to virulence in a systemic mouse model of candidiasis, it does
affect virulence in an tissue culture model of oropharyngeal candidiasis (OPC) using a FaDu cell
line, as well as a modest role in virulence in the mouse OPC model (31, 71).
The immune response to C. albicans
C. albicans inhabits the gastrointestinal (GI) tract primarily as a yeast-form and as a
commensal does not typically cause disease (72). The intestines are protected from invasion of
normal flora by the intestinal mucosal barrier, which consists of a physical barrier as well as an
immunological barrier (part of the initial immunological recognition is mediated by Peyer’s
patches, which play a part in sensing overgrowth in the GI tract and prevent invasion into the
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host tissue) (73). This is the first line of defense the host has against the fungus, but can
become compromised in those who are immunocompromised. If a breach in the physical
barriers of the host occur, the immune system plays an important role in elimination of C.
albicans and is critical for the survival of the host.
The main purpose of the yeast cell wall is to protect it from environmental stress such as
osmolarity and detect its surroundings, but can also serve an important role in concealing it from
the immune system (74-76). In systemic bloodstream infections of C. albicans (known as
candidiasis), the cell wall surface helps conceal C. albicans from recognition from the innate
immune system by concealing its main pathogen-associated molecular pattern (PAMP) ß-(1,3)
glucan, which enables the pathogen to disseminate with minimal detection by the innate
immune system (77, 78). The surface of the cell wall largely consists of a thick layer of heavily
mannosylated proteins, which conceals/masks the ß-(1,3) glucan underneath (79-81). When the
innate immune system detects structural ß-(1,3) glucan sugars they elicit a pro-inflammatory
response, promoting elimination of the infection (82, 83).
While the innate immune system predominantly plays a role in systemic infections, the
adaptive immune response can play a role in mucosal infections, resulting in a pro-inflammatory
Th1 response (84). Examples of these infections are oropharyngeal candidiasis as well as over
colonization of the vaginal tract, both which can lead to discomfort to those whom that are overcolonized.
Phagocytic effector cells of the innate immune system like neutrophils and macrophages
are the first line of defense against systemic fungal infections (such as candidiasis). These
effector cells detect fungi by binding ß-(1,3) glucan in the fungal cell wall with a C-type lectin
signaling protein called Dectin-1 that is found on a number of innate immune effector cells, and
induces production of pro-inflammatory cytokines such as TNFα as well as yeast phagocytosis
(82, 85, 86). Apart from Dectin-1, there is Dectin-2 which can detect mannan (82, 85). These
Dectin receptors are C-type lectin transmembrane receptors (87). Dectin-1 can mediate
9

signaling by itself with a tyrosine-based action motif (ITAM); in contrast, the Dectin-2 receptor
requires an associated adaptor molecule for ITAM-based activation (88). Once binding of their
appropriate ligand occurs, these Dectin receptors will be phosphorylated on a tyrosine residue
by the spleen tyrosine kinase (syk), a protein tyrosine kinase (89). Once phosphorylated, the
Dectin-1 receptor initiates a signaling cascade that promotes phagocytosis, release of reactive
oxygen species (ROS) and cytokine release (Fig. 1.3) (89)
Separately from these fungal-specific receptors, toll like receptors (TLRs) 2 (which
recognizes phospholipomannan) and 4 (which recognize O-bound mannans) play an important
role in the innate immune response. While these receptors are able to bind fungal components,
TLR2 is also able to bind and recognize peptidoglycan, a predominant cell wall component of
gram + bacteria, and TLR4 is a classical LPS receptor, which makes them versatile signaling
receptors in the innate immune system (90, 91). Once activated, these receptors associate with
MyD88 to activate the transcription factor NFκB and results in pro-inflammatory macrophage
proliferation (92). In addition, some receptors have synergy with one another (such as TLR2 and
Dectin-1) which together promote phagocytosis by macrophages and a TNFα response (87, 93).
Lastly, there is the mannose receptor (MR) that recognizes oligosaccharides that terminate in
mannose and N-acetyl glucosamine (94, 95).
Apart from effector cells, there are bloodstream components such as defensins and
histatins that can destroy C. albicans outright based on the surface charge of the microbe (96),
which may be mediated by either changes in the cell wall, cell membrane, or both. Complement,
another non-cellular component of the immune system, in particular the C3 component, has
been implicated in C. albicans colonization of mucosa and may play a role in controlling
colonization (97). C3b and iC3b in particular can bind to C. albicans, and result in opsonization
(78). These complement components cannot kill the yeast outright due to their protective thick
cell wall structure but opsonization mediates recruitment of inflammatory cells (78).In addition to
C3b, C3d is known to directly bind to β-(1,6) glucan, an important structural component of the
10

cell wall, and binding of these C3 components ultimately results in the recruitment of neutrophils
to the site of colonization (98). In conclusion, neutrophils are the major component of the innate
immune system that deals with C. albicans bloodstream infections, with complement and
macrophages playing a minor role in cytokine production and labeling the C. albicans’ cell wall.
Due to the fact that our cho1∆/∆ mutant has severe cell wall defects, we were curious as
to whether this would result in exposure of cell wall components that could be recognized by the
immune system (44). In Chapter 2, I will discuss how a loss of phosphatidylserine synthesis by
the cho1∆/∆ mutant results in an increased exposure of β-(1,3) glucan and an increased
recognition by macrophages.
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Appendix. Chapter I Figures

Figure 1.1. Representation of the various morphologies that C. albicans can exhibit. A
yeast form, B pseudo-hyphae form and C Hyphae. Figure from Joseph Chen’s dissertation.
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Figure 1.2. There are significant differences between humans and C. albicans in the enzyme
involved in the de novo synthesis of phosphatidylserine (PS). Cho1p does not have a homolog
in mammals.
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Figure 1.3. The Dectin-1 receptor is expressed on the surface of macrophages, dendritic
cells and neutrophils. The Dectin-1 receptor mediates binding to ß-(1,3) glucan. Normally,
Candida albicans has a cell consisting of chitin at the base, then ß-(1,3) glucan and ß-(1,6)
glucan in the center and the surface is coated with mannoproteins. These mannoproteins
conceal the glucan underneath, preventing Dectin-1 binding (top part of figure). However with
certain cell wall mutants, there is a loss of the mannoprotein coat resulting in exposure of
glucan resulting in binding of the Dectin-1 receptor. This binding induces phagocytosis of the
bound target, as well as production of the cytokine TNFα as well as reactive oxygen species
(ROS) (bottom part of figure). Figure adapted from a previous publication (99).
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Chapter II: ß-(1,3) glucan is unmasked in a phosphatidylserine synthase mutant
(cho1∆/∆), which leads to an innate immune response mediated by the Dectin-1 receptor
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Abstract
The virulence of Candida albicans in a mouse model of invasive candidiasis is
dependent on the phospholipids phosphatidylserine (PS) and phosphatidylethanolamine (PE).
Disruption of the PS synthase gene CHO1 (i.e., cho1∆/∆) eliminates PS and blocks the de novo
pathway for PE biosynthesis. In addition, the cho1∆/∆ mutant’s ability to cause invasive disease
is severely compromised.
The cho1∆/∆ mutant also exhibits cell wall defects, and in this study, it was determined
that loss of PS results in decreased masking of cell wall β-(1,3) glucan from the immune system.
In wild-type C. albicans, the outer mannan layer of the wall masks the inner layer of β-(1,3)
glucan from exposure and detection by innate immune effector molecules like the C-type
signaling lectin Dectin-1, which is found on macrophages, neutrophils, and dendritic cells. The
cho1∆/∆ mutant exhibits increases in exposure of β-(1,3) glucan, which leads to greater binding
by Dectin-1 in both yeast and hyphal forms. The unmasking of β-(1,3) glucan also results in
increased elicitation of TNF-α from macrophages in a Dectin-1-dependent manner. The role of
phospholipids in fungal pathogenesis is an emerging field, and this is the first study showing that
loss of PS in C. albicans results in decreased masking of β-(1,3) glucan, which may contribute
to our understanding of fungus-host interactions.
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Introduction
Both the innate and adaptive immunological responses of the host play a role in
controlling and eliminating fungal infections, but the innate response is the early responder and
is crucial for controlling bloodstream infections (100-102). The innate response is mediated
largely by phagocytic cells such as macrophages and neutrophils, which recognize,
phagocytose, and kill the pathogen (103). Recognition is dependent, in part, on pathogenassociated molecular patterns (PAMPs) that are present on the surface of the pathogen, which
can then be recognized by phagocytic pattern recognition receptors (PRRs) (104-107). Fungal
cell walls contain the PAMP ß-(1,3) glucan . The fungal wall is composed of two relatively
indistinct layers; mannosylated proteins (mannan) are enriched on the outer surface layer, and
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ß-(1,3) glucan and chitin are enriched in the layer beneath (Fig. 2.2) (108, 109). ß-(1,3) glucan
is a known PAMP that is recognized by Dectin-1, a C-type lectin PRR that is expressed by
macrophages, neutrophils, and dendritic cells (104). Several cell wall mutants with increased
exposure of ß-(1,3) glucan also exhibit increased recognition by phagocytic cells, resulting in
increased phagocytosis by macrophages and production of cytokines, inducing a strong
response by the innate immune system that may play a role in the faster elimination of these
mutants (110, 111). In this communication, we report that the loss of PS in the C. albicans
cho1∆/∆ mutant results in changes in cell wall structure, notably, an increase in ß-(1,3) glucan
exposure on the cell surface. The full mechanism of how phospholipids affect the cell wall is not
known, but it may relate to the manner in which phospholipids like PS modulate signaling
pathways like calcineurin, protein kinase C, Hog1p, or Cek1p, which regulate the cell wall (112,
113). Increased ß-(1,3) glucan exposure induces increased Dectin-1 binding, mediating
macrophage release of the cytokine tumor necrosis factor alpha (TNFα). The TNFα response is
important in protecting against systemic candidiasis, and when the TNFα response is ablated by
either knocking out or neutralizing the TNFα response with an anti-TNFα antibody, mice are
more susceptible to systemic candidemia (114, 115). Interestingly, we find that the psd1∆/∆
psd2∆/∆ double mutant does not exhibit these phenotypes as strongly, suggesting that PS is
specifically required for ß-(1,3) glucan “masking” from immune recognition.
Results
Previous work has shown that the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants show poor
hyphal formation on plates in response to a neutral pH or Spider medium, a medium that is poor
in nutrients and that promote hyphal formation. However, the cho1∆/∆ and psd1∆/∆ psd2∆/∆
mutants could both form hyphae in response to mouse serum (44). These previous data were
only qualitative, and it was not clear whether the mutants grew as hyphae at a rate similar to
that of the wild type in response to serum. Consequently, the hyphal extension rates of the
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cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants were compared to those of the wild type and psd1∆/∆
mutants in human serum by time-lapse microscopy. Through this assay, it was found that all of
the strains except the cho1∆/∆ mutant exhibited similar hyphal extension rates, with the cho1∆/∆
mutant exhibiting a slightly shorter hyphal growth; however the difference was not statistically
significant (Fig. 2.2 A, Videos A1-4).
In order to determine if these mutants could also form hyphae in response to more in
vivo stimuli, such as host tissue, the strains were compared for growth after they infected mice
and were localized to the kidneys. Each strain was transformed with a construct that would
express cytoplasmic GFP from the constitutive ENO1 promoter (116). Then yeast-form cells of
each strain were stained on the exterior with Alexa Fluor 555 dye and administered to mice via
tail vein injection. Kidney homogenates were analyzed by microscopy 6 h after infection to
determine if hyphal growth occurred in the kidney. The Alexa Fluor stain allows the identification
of injected yeast-form cells, and GFP-expressing hyphae that lack Alexa Fluor staining indicate
new growth after infection of the kidney. Analysis of kidney homogenates revealed that all four
strains were able to survive and grow similarly within the mouse (Figs. 2.2 B & C). Thus, when
grown under host-simulating conditions, the mutants appear to form hyphae at a rate similar to
that of the wild type, at least for several hours.
Loss of PS results in increased exposure of ß-(1,3) glucan on the C. albicans yeastform cell surface. In a previous report, the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants’ cell wall
defects were studied in the context of yeast-form cells grown at 30°C in rich medium (YPD). In
these studies, the cho1∆/∆ mutant exhibited stronger cell wall defects than the psd1∆/∆ psd2∆/∆
mutant, including a much greater increase in chitin levels than in wild-type cells and a thicker,
more irregular cell wall, as shown by transmission electron microscopy (44). It was
hypothesized that these cell wall defects would correlate with phenotypes that impact virulence,
such as increased exposure of ß-(1,3) glucan , which affects host-pathogen interactions. We
examined the effects of these mutations on ß-(1,3) glucan exposure by immunofluorescence
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with an anti- ß-(1,3) glucan antibody (110). ß-(1,3) glucan is noticeably more exposed in the log
and stationary phases of cho1∆/∆ mutant cells than in wild-type, cho1∆/∆::CHO1, psd1∆/∆, or
even psd1∆/∆ psd2∆/∆ mutant cells (Fig. 2.3 A & B). ß-(1,3) glucan on the surface of C.
albicans is bound and detected by Dectin-1, a C-type lectin that is expressed on innate immune
effector cells such as macrophages, neutrophils, and dendritic cells (110, 117). This binding and
recognition aids macrophages and neutrophils in the phagocytosis of yeast and results in the
secretion of cytokines like TNFα (110, 118). Fluorescent staining with sDectin-1–Fc reveals that
cho1∆/∆ mutant yeast-form cells exhibit greater binding by Dectin-1 than the other strains (Fig.
2.4 A). Flow cytometry to quantify the binding of sDectin-1–Fc to the surface of yeast-form C.
albicans supports the microscopy results and indicates that the cho1∆/∆ mutant has significantly
greater binding by Dectin-1 than the other strains and that the psd1∆/∆ psd2∆/∆ double mutant
(solid pink line) does not differ from the wild type (black) (Fig 2.4 B). The cho1∆/∆ cells exhibit
an average increase in binding by Dectin-1 over wild type of approximately 58% (Fig 2.4 C).
These results support those showing increased anti- ß-(1,3) glucan staining exposure on the
cho1∆/∆ mutant cell surface (Fig. 2.4). ß-(1,3) glucan is bound by Dectin-1, but there are data
that suggest that anti- ß-(1,3) glucan antibody and sDectin-1–Fc may bind to somewhat distinct
epitopes (110). If so, then it should be possible to see co-localization of staining with both
probes. To assess this, yeast-form cells were double stained with an anti ß-(1,3) glucan
antibody and sDectin-1–Fc and secondary antibodies with differential fluorophores. It is clear
that the signals co-localized and are very prominent for the cho1∆/∆ mutant (see Fig. A1).
Phospholipid mutants generate hyphae when growing in human serum. Since the cho1∆/∆ but
not the psd1∆/∆ psd2∆/∆ mutant cells exhibit increased exposure of ß-(1,3) glucan in the yeast
form, the effects of these mutations on the exposure of ß-(1,3) glucan in hyphae needed to be
addressed to determine if there were any cell wall differences that are dependent on
morphology.
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Loss of PS increases exposure of ß-(1,3) glucan in hyphae
The cho1∆/∆ mutant exhibits a greater exposure of ß-(1,3) glucan than the wild-type,
psd1∆/∆ psd2∆/∆ double mutant, and other strains in yeast form (Figs. 2.3 A & B, Fig. A1). In
order to determine if this held true for hyphae as well, cells were grown in human serum at 37°C
to induce hyphal growth and then stained for ß-(1,3) glucan exposure with an anti- ß-(1,3)
glucan antibody. When staining the C. albicans’ hyphae with sDectin-1–Fc or an anti-ß-(1,3)
glucan antibody was performed, only the cho1∆/∆ mutant exhibited strong staining with either
probe, and the staining, like that in yeast-form cho1∆/∆ mutant cells, was found in overlapping
patterns (Fig 2.5 A & B, Fig. A2). In addition, a number of the hyphae of the cho1∆/∆ and
psd1∆/∆ psd2∆/∆ mutants were also malformed compared to those of the wild-type and psd1∆/∆
strains They were enlarged at the tips in comparison and in many cases were somewhat curved
near the tip (Fig. 2.5 A, enlargement indicated by arrows). Approximately 48% of the cho1∆/∆
mutant hyphae and 52% of the psd1∆/∆ psd2∆/∆ mutant hyphae showed this phenotype,
whereas none of the other strains exhibited this phenotype (Table 3). The frequency of colocalization of anti- ß-(1,3) glucan antibody and Dectin-1 staining was quantified for all of the
strains, revealing that they bind to unfixed hyphal cells similarly for the most part (Fig. A3). The
psd1∆/∆ and psd1∆/∆ psd2∆/∆ mutants did have stronger staining than the wild type, but it was
generally much weaker than that of the cho1∆/∆ mutant strain. Interestingly, for many of the
mutants staining with sDectin-1–Fc tended to be stronger for the mother yeast cells when they
were grown in serum (Fig. A2).
Phospholipid mutants are not more susceptible to killing by innate immune responses.
As our cho1∆/∆ mutant has increased ß-(1,3) glucan exposure and increased binding by
sDectin-1–Fc, it was hypothesized that increased binding of Dectin-1 would result in increased
susceptibility to killing by macrophages. However, when in vitro killing assays were performed
with macrophages (RAW264.7 or Raw BLUE), it was found that there was no difference in
killing for any of the strains (Fig. 2.6 A). Neutrophils are typically more efficient at killing C.
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albicans than macrophages, so the susceptibility of the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants
to neutrophils was also tested. However, the mutants were not more readily killed by neutrophils
either (Fig. 2.6 B). In addition to cellular innate immune responses, it is also possible that the
mutants might be more susceptible to non-cellular innate immune response elements like
cationic peptides, as membranes of our cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants are defective
(44). We tested the susceptibility of our mutants to the human cationic peptide β-defensin, which
is known to act against the negatively charged membranes of invading pathogens and can play
a role in mucosal defense against C. albicans (96, 119-121). Surprisingly, the cho1∆/∆ mutant
appeared to be more resistant than the wild type to β-defensin at a concentration of 500 nM, but
these values were not statistically significant. The psd1∆/∆ and psd1∆/∆ psd2∆/∆ mutants
showed no differences (Fig. 2.6 C) from the wild type. In addition, the mutants showed no
difference in binding by complement C (data not shown).
Loss of PS in C. albicans causes increased elicitation of cytokines from macrophages.
Increased exposure of ß-(1,3) glucan in C. albicans cell wall mutants has been shown to
cause an increase in TNFα release from macrophages (110). The differences in ß-(1,3) glucan
exposure reported in the cho1∆/∆ mutant was hypothesized to cause an increase in TNFα
production. A TNFα-specific ELISA revealed that the cho1∆/∆ mutant elicits greater TNFα
production from RAW-BLUE macrophages than the wild type strain (Fig. 2.7 A). This is not the
case for the reintegrant psd1∆/∆, or psd1∆/∆ psd2∆/∆ mutant strain. The Dectin-1 receptor
expressed on immune effector cells binds to ß-(1,3) glucan on the C. albicans cell surface, and
this has been reported to trigger TNFα release (117). Thus, Dectin-1 was presumed to be
responsible for the increase in TNFα release. In order to rule out other non-Dectin-1 receptors
as mediators of increased TNFα production by macrophages in response to the cho1∆/∆
mutant, an anti-Dectin-1 antibody was administered to the macrophages prior to their exposure
to cho1∆/∆ mutant cells in order to block Dectin-1 activation during co-incubation with yeast
cells. The results in Fig. 2.7 A show that blocking of Dectin-1 reduces TNFα production to nearly
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wild-type levels, revealing that Dectin-1 is responsible for cytokine release. When the RAW
264.7 macrophage cell line was used, a similar elicitation of TNFα in a Dectin-1-dependent
manner was observed as well (see Fig. A4). In addition to these data, it was determined that
there was an statistically significant increase in phagocytosis of the cho1∆/∆ mutant by RAWBLUE macrophages after an 8 hour incubation, which is a typical reaction of macrophages to
yeast in the bloodstream (Fig. 2.7 B) (122).
Discussion
Loss of the PS synthase gene CHO1 results in changes in immune recognition, most
notably, increased exposure of ß-(1,3) glucan in the cell wall. The increased exposure of β (13)-glucan can be seen from the increased binding of anti- ß-(1,3) glucan antibodies (Fig. 2.3 A &
B). On the basis of current models, this may be due to glycosylated cell surface proteins on the
cho1∆/∆ mutant cell wall not adequately concealing the layer of ß-(1,3) glucan underneath,
causing “chinks” in the masking of this important yeast cell wall PAMP. These differences in ß(1,3) glucan exposure in the cho1∆/∆ mutant are also supported by Dectin-1 receptor binding to
both yeast-form (Fig. 2.4 A) and hyphal cells (Fig. 2.5 B) and elicitation of TNFα (Fig. 2.7 A, Fig.
A4). These data reveal that the immune response to the cho1∆/∆ mutant is stronger than that to
all of the other strains tested. The more severe defects in immune evasion in the cho1∆/∆
mutant (lacks PS and has deficient PE) than the psd1∆/∆ psd2∆/∆ double mutant, which has
deficient PE but abundant PS, reflect the stronger cell wall deficiencies of the cho1∆/∆ mutant
(44). The loss of PS for the cho1∆/∆ mutant may also affect the membrane charge of the cell,
which would reduce the negative surface charge that defensins are known to interact with. This
may explain why the cho1∆/∆ mutant appears to be more resistant to human β-defensin 2, as it
has a different surface charge than any of the other strains we tested (Fig. 2.6 C).
The correlation between increased ß-(1,3) glucan exposure and increased TNFα
production in the cho1∆/∆ mutant is notable, as Wheeler and Fink (110) found some mutants of
Saccharomyces cerevisiae that exhibit increased binding by anti- ß-(1,3) glucan antibody but
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did not necessarily bind better to Dectin-1 or hyper-elicit TNFα. Thus, while increased staining
by anti- ß-(1,3) glucan antibody does not always correlate with increased immune recognition,
the increase that occurs in the cho1∆/∆ mutant does yield a more productive immune response
as well as increased phagocytosis (Fig. 2.7 A & B, Fig. A4). These data suggest that the loss of
PS alone is responsible for unmasking in C. albicans, and this conclusion is drawn from the
following observations. (i) Loss of CHO1 results in a complete loss of PS and a 40% drop in PE
levels, since this population of PE molecules is derived from PS by decarboxylation via Psd1p
or Psd2p (44). (ii) Loss of PSD1 and PSD2 simultaneously (psd1∆/∆ psd2∆/∆) causes a 40%
drop in PE similar to that observed in the cho1∆/∆ mutant, but there is an increase in PS, since
it is not converted to PE by decarboxylation. (iii) Although the cho1∆/∆ and psd1∆/∆ psd2∆/∆
mutants have similar drops in PE, only the cho1∆/∆ mutant, with its lack of PS, shows a strong
increase in ß-(1,3) glucan exposure by staining with anti-β (1-3)-glucan antibody or sDectin-1–
Fc (Fig. 2.3 A & B, Fig. 2.4 A, Fig. 2.5 A & B, Figs. A1 & A2) and increased elicitation of TNFα
from macrophages (Fig. 2.7 A, Fig. A4). Thus, it appears that the loss of PS is responsible for
the majority of the increased exposure of ß-(1,3) glucan . There is a subtle contrast between the
hyphal form and the yeast form in regard to ß-(1,3) glucan exposure. In particular, although
cho1∆/∆ mutant hyphae have the strongest exposure of ß-(1,3) glucan , the psd1∆/∆ and
psd1∆/∆ psd2∆/∆ mutants also exhibit greater exposure of ß-(1,3) glucan and binding of
sDectin-1–Fc than the wild type, but exposure is lower than that of the cho1∆/∆ mutant (Fig. 2.5
A & B).
Thus, for hyphae, the defect in masking is affected primarily by PS but is impacted by
PE as well. We did not test to see if this difference in the hyphal form leads to greater TNFα
release in macrophages because of technical difficulties when working with hyphae in this
assay, as they were susceptible to aggregations and hence difficult to distribute evenly to
macrophages for stimulation to elicit TNFα. Alternatively, these data may indicate that ß-(1,3)
glucan is more readily unmasked in the psd1∆/∆ psd2∆/∆ mutant along with the cho1∆/∆
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mutant, than in the psd1∆/∆ mutant. This could be of interest, as the unmasking that occurs
under these conditions correlates with these strains’ defects in virulence.
The precise defect that leads to increased exposure of ß-(1,3) glucan in yeast-form cells
of the PS synthase mutant alone is unclear. This increase does not appear to resemble that of
the kre5∆/∆ mutant, which has increased exposure all over the cell surface (110). Instead, the
increased exposure we observe is localized to foci at the periphery of yeast-form cells providing
a punctate appearance to the exposure (Fig. 2.3 A & B, Fig. A1). These increases also do not
correlate with bud scars (data not shown). Transmission electron microscopy images of cho1∆/∆
mutant cells reveal irregularities in the membrane and cell wall that look like invaginations (44).
The increased exposure of ß-(1,3) glucan in the cell wall of the cho1∆/∆ mutant may
correspond to these irregularities, although that remains to be determined. The mechanism by
which PS controls β (1-3)-glucan masking could be related to effects of PS on cell wall signal
transduction pathways, general endocytic trafficking, or alterations of the plasma membrane
(123, 124). A number of cell wall signaling pathways are directly affected by PS, including the
protein kinase C (Pkc1p) and calcineurin pathways (125-129). In S. cerevisiae, PS is a cofactor
for ScPkc1p activity in vitro. In addition, calcineurin is recruited to membranes by PS in vitro.
Therefore, these pathways could potentially affect the cell wall because of PS loss. The role that
ß-(1,3) glucan exposure in the cho1∆/∆ mutant plays in compromising virulence in the host is
not clear. The yeast form of the cho1∆/∆ mutant elicits a greater release of cytokines from
macrophages than the psd1∆/∆ psd2∆/∆ mutant and has more exposure of ß-(1,3) glucan as
yeast cells or hyphae, suggesting a stronger immune response. However, these mutants are
pleiotropic, so there are likely other mechanisms at work in addition to unmasking to affect
virulence. For example, both mutants are ethanolamine auxotrophs (44). Even in YPD, which
contains ethanolamine, the cho1∆/∆ mutant has a 2.5-fold lower growth rate than the wild type,
which suggests that the growth rate could play a role in the cho1∆/∆ mutant’s ability to be
pathogenic; however, it can clearly grow for several hours in serum or in the host (Fig. 2.2 A, B
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& C), but this may not translate into growth over several days, which is required to overwhelm
the host during sepsis. Thus, the mutants may not be getting enough ethanolamine to make
sufficient PE, which is essential (44), as it is in other yeasts like S. cerevisiae and
Schizosaccharomyces pombe (130). Alternatively, auxotrophy may play a role, but the
increased exposure of ß-(1,3) glucan may result in more rapid clearance of the mutant. PS
clearly affects the cell wall and masking independently of PE, but PE appears to at least subtly
affect the cell wall in hyphae. These defects compromise an important defensive virulence factor
of fungi, “masking” of the cell wall PAMP ß-(1,3) glucan. This report sets the stage for a better
understanding of how PS and PE regulate pathways that ultimately affect virulence traits and
cell wall physiology in this pathogen.
Materials and Methods
Purification of sDectin-1–Fc.
HEK293T cells were transfected with the soluble Dectin-1–Fc (sDectin-1–Fc) construct
previously described (131). After selection for stable transfection with Zeocin, the cells were
seeded into a CELLine AD1000 bioreactor (Wheaton) and cell supernatants were harvested
twice weekly. Supernatants were purified over Hi-Trap protein A columns (GE Healthcare) and
dialyzed overnight with phosphate-buffered saline (PBS) in Slide-A-Lyzer Dialysis cassettes
(Thermo Scientific). Dialyzed supernatants were concentrated with Amicon
Ultra centrifugal filters (Millipore). Elution from the column directly into 1 M Tris (pH 9)
neutralization buffer was performed under low-pH conditions with 100mMglycine (pH 2.8). The
concentration of sDectin- –Fc was determined with the Bradford assay.
sDectin-1–Fc staining and flow cytometry.
C. albicans strains were streaked onto YPD agar plates and left at 37°C overnight. A
single colony per strain was picked and transferred into 5 ml YPD liquid, which was put into a
rotator wheel and left overnight at 37°C. A sample of culture was centrifuged and washed three
times with PBS. Samples were blocked in PBS plus 2% bovine serum albumin for 1 hour at
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room temperature. After blocking, samples were stained with sDectin-1–Fc at 16.5 µg/ml for 1.5
h on ice. Samples were washed with PBS five times and then stained with donkey anti-human
IgG DyLight 488 antibody (Jackson ImmunoResearch) at 0.83 µg/ml for 20 min on ice. Samples
were washed five times with PBS and then resuspended in 500 µl PBS for flow cytometry. Flow
cytometry data were obtained for 10,000 gated events per strain, and statistics were calculated
with the paired Student t test. For imaging, Candida cells were prepared as outlined above but
were resuspended in 50 µl PBS and visualized with a Zeiss AxioVision Vivotome microscope
(Carl Zeiss Microscopy, LLC). This experiment was repeated twice.
In other immunofluorescence experiments with sDectin-1–Fc staining, donkey antihuman IgG-Cy3 or rabbit-anti-human IgG-Cy2 (both from Jackson ImmunoResearch) was used
as the secondary antibody.
Immunofluorescence of ß-(1,3) glucan and complement.
Strains were grown overnight in YPD at 30°C. For yeast-form staining, 0.1 optical
density (O.D) unit of each strain was washed three times with PBS. Blocking and primary and
secondary antibody incubations occurred on ice in PBS plus 3% bovine serum albumin.
Blocking was for 1 hour, primary-antibody incubation was for 1.5 hour, and secondary-antibody
incubation was for 20 minutes with five washes between antibodies. An anti- ß-(1,3) glucan
antibody (Biosupplies Australia) at a 1:800 dilution was used as the primary antibody, and a
goat anti-mouse antibody conjugated to Cy3 (Jackson ImmunoResearch) at 1:600 was used as
the secondary antibody. For hyphal form staining (see Fig. 2.5, Fig. A2), overnight cultures
grown at 30°C were washed three times with PBS, added to 20% human serum in RPMI in LabTek glass chamber slides (Thermo Scientific), and incubated at 37°C for 3 hours to ensure
adequate filamentation. Antibody staining was performed in the same way as yeast-form
staining. A formaldehyde fixation step with 37% formaldehyde in PBS was used for yeast and
hyphae in some cases before staining began, and this is noted in the figure legends if that was
the case.
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Complement staining with the primary antibody against human C1q-c complement
(Santa Cruz catalog no. sc-365301) (132) and a Cy3- conjugated anti-mouse secondary
antibody (Jackson ImmunoResearch) was performed with overnight cultures grown at 30°C that
were washed three times with PBS. The yeast cells were then incubated with 50% human
serum for 30 minutes and then stained according to the yeast-form immunofluorescence
protocol.
For all immunofluorescence studies, experiments were repeated in triplicate. In each
experiment, n=100 for yeast cells and 20 for hyphae.
Quantification of immunofluorescence signal of hyphae for ß-(1,3) glucan and Dectin-1
immunofluorescence.
The fluorescence intensities of labeled hyphae were assessed with NIS-Elements AR
3.2 image analysis software (Nikon Instruments Inc., Melville, NY). Hyphae were viewed by
using a rainbow display scale of pixel intensity and assigned a score based on fluorescence
intensity (red=high [3], yellow=medium [2], green=low [1].
Strains and growth media
All of the strains used for these experiments are described in Table 1 or derived from
these strains. Strains were cultured in YPD liquid medium (1% yeast extract, 2% peptone, 2%
glucose) or on YPD agar plates (133). The RAW264.7 mouse-derived macrophage cell line
(134) and human neutrophils were both cultured in RPMI plus 10% fetal bovine serum and 1X
penicillin-streptomycin (Gibco). The RAW-BLUE cells that expressed elevated levels of Dectin-1
were cultured in the same medium as RAW264.7 macrophages, only with the addition of 200
µg/ml Zeocin (Research Products International Corporation). For the generation of strains that
express cytoplasmic green fluorescent protein (GFP) constitutively under the control of the
promoter of the gene for enolase (ENO1), we used the plasmid pENO1-yEGFP3-NAT (116) and
transformation methods that have been previously described (135). To generate the
cho1∆/∆::CHO1 reintegrant strain that expresses GFP, the
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SAT1 marker was flipped out of the CHO1 reintegration construct (pCHO1-SAT1-flipper) (strain
SED022) and then transformed with the above-described GFP plasmid using nourseothricin
selection at a concentration of 200 µg/ml (Werner BioAgents).
Killing assays
Killing assays were performed with macrophages and neutrophils. Neutrophil isolation
was done by a method adapted from a previously published protocol (136). Neutrophils were
obtained from whole blood from a human donor. The blood was diluted with an equal volume of
PBS, Lymphocyte Separation medium (BioWhittaker) was underlaid, and the cells were
centrifuged to pellet neutrophils and erythrocytes. The pellet was subjected to 3% dextran
sedimentation to isolate neutrophils and further treated with 0.2% sodium chloride to lyse any
residual erythrocytes. Yeast-form cells (from an overnight culture grown in YPD) and
phagocytes were co-incubated at a 1:40 ratio for 2 hours at 37°C and 5%CO2, and afterward,
yeast cells were plated on YPD plates for total colony form units (CFU) counting. The
experiment was performed three separate times, and for each strain in an individual experiment,
n=5, for a total of n=15 for each strain.
ELISA of TNFα
RAW264.7 macrophages were plated the day prior at 5*105/well in a 24-well plate.
Macrophages and UV-killed yeast-form Candida cells were co-incubated at a 1:10 ratio for 8 h
at 37°C and 5%CO2. The enzyme-linked immune-sorbent assay (ELISA) kit instructions of the
manufacturer (R&D Systems) were followed. To determine if the release of TNFα was due to
Dectin-1 binding, a commercial anti-Dectin-1 neutralizing antibody (InvivoGen MAb-mDect) was
administered to the macrophages for 1 h prior to co-incubation at a concentration of 100 ng/ml.
Three individual experiments were performed. For each of these experiments, three individual
wells were stimulated for 8 hours with the RAW 264.7 macrophage cell line or for 4 hours when
RAW-BLUE macrophages were used (For RAW-BLUE the setup for the experiment was the
same). From each well, the sample was taken and measured in triplicate, for a total of nine data
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points per group. Statistical analysis of the data was performed by the unpaired-sample t test
with two-tailed P values. The RAW 264.7 macrophages were a gift from Dr. Chunlei Su at the
University of Tennessee, and the RAW-BLUE were a gift from Dr. Robert Wheeler at the
University of Maine.
β-Defensin Assay
By using a protocol adapted from reference (137), strains were grown overnight in YPD
at 30°C, washed with 10 mM sodium phosphate buffer (NaPB), and counted with a
hemacytometer and 105 cells were incubated with various concentrations of human β-defensin 3
(AnaSpec catalog no. 60741) for 1 hour in 10mMNaPB in a shaking incubator at 37°C. After
incubation, cells were washed with 10 mM NaPB, diluted 1:100, and plated for CFU counting.
The assay was performed three separate times. For each strain in each assay, n = 4. Statistical
analysis of the data was performed by the unpaired-sample t test with two-tailed p-values.
Time-lapse microscopy of hyphal formation
A 2% agarose gel was overlaid on the surface of a Delta T dish (Bioptechs, Inc.) with
wells formed in the gel to contain medium and yeast. Strains were grown overnight in YPD at
30°C and washed with PBS, and cells were counted with a hemacytometer. RPMI plus 25%
human serum was added to the wells, and 5 *103 yeast cells were added to each well. The
Delta T dish was placed on a heated stage set to 37°C and imaged automatically to determine
hyphal length over a 3 hour period. Hyphal length was determined by software analysis (NISElements version 3.1; Nikon Instruments). Quantification was performed by monitoring 20 cells
of each strain.
In vivo hyphal formation
GFP-expressing strains were washed with PBS and stained with Alexa Fluor 555
(Invitrogen) in 100 mM NaCO3 buffer (pH 10) for 30 minutes at room temperature. After cells
were washed three times in PBS, 107 cells were injected per mouse via the tail vein. After 6
hours, the mice were sacrificed and their kidneys were removed and immediately homogenized
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with a Dounce tissue homogenizer and visualized by microscopy. This experiment was
performed in triplicate with two or three mice per genotype, so there were eight or nine mice per
strain. For each experiment, both kidneys of each mouse were homogenized together and
visualized to look for yeast cells. A minimum of 3 cells from each pair of kidneys were imaged,
for a minimum of 24 to 27 cells of each strain.
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Appendix. Chapter II Figures

Figure 2.1. The structure of the fungal cell wall with the different polysaccharide and
protein components depicted. (Image adopted from science.kennesaw.edu/fungalcellwall)
(adapted by Anthony Montedonico, in dissertation at UTK).
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Figure 2.2. Hyphal formation of the cho1∆/∆ mutant is not significantly impaired in serum
or host tissue. A C. albicans strains were incubated in 100% human serum and were
observed by time lapse microscopy on thermally regulated glass slides. After 3 hours the length
of the hyphae was measured as an indicator of growth over time. B C. albicans strains
expressing GFP were stained with Alexa Fluor dye during yeast form growth. Stained yeast
cells were then injected into mice via the tail-vein and after 6 hours mice were sacrificed,
kidneys were removed, and then homogenized and viewed by microscopy. Hyphae expressing
GFP indicate new growth that occurred within the mouse tissue. C Percentage of yeast
inoculated in vivo that generated hyphae in the kidneys.
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Figure 2.3. A The stationary-phase and log-phase yeast form of the cho1Δ/Δ mutant
exhibits increased exposure of ß-(1,3) glucan . A Immunofluorescence using an anti-ß1,3glucan primary antibody reveals that the cho1Δ/Δ mutant has increased ß-(1,3) glucan
exposure in comparison to the other strains in both stationary phase (A) and log-phase (B).
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Figure 2.4. The cho1Δ/Δ mutant in yeast form has increased binding to the Dectin-1
receptor. A C. albicans strains grown overnight in YPD were stained with sDectin-1-Fc and
fluorescently labeled secondary antibody, showing that the cho1Δ/Δ mutant exhibits greater
staining than all other strains. B Flow cytometry reveals that the cho1Δ/Δ mutant has greater
binding to the Dectin-1 receptor in comparison to other strains. C A graph of average mean
fluorescent intensity from each sample reveals that the cho1Δ/Δ mutant exhibits significantly
greater staining with sDectin-1-Fc than the other strains. * p-value < 0.05.
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Figure 2.5. The hyphal form of the cho1Δ/Δ mutant has increased exposure of ß-(1,3)
glucan and binding by the Dectin-1 receptor. A Immunofluorescence of ß-(1,3) glucan
exposure using a anti-ß1,3-glucan antibody reveals that the cho1Δ/Δ mutant and the psd1Δ/Δ
psd2Δ/Δ double mutant have increased ß-(1,3) glucan exposure in comparison to the wild type
and psd1Δ/Δ mutants. This exposure appears to localize at malformed tips of the hyphae
(indicated by arrows). B Immunofluorescence using sDectin-1-Fc and secondary antibody
shows that the cho1Δ/Δ mutant exhibits greater binding to Dectin-1 than the other strains.
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Figure 2.6. There are no differences in killing by phagocytes or defensins. A RAW 264.7
macrophages and C. albicans cells were co-incubated for 8 hours and C. albicans plated to
measure viable CFUs. C. albicans strains mock challenged with macrophages were used to
calculate the percentage of C. albicans killed. B Neutrophils were measured for their ability to
kill the different strains using the same approach as in A, except that they were co-incubated for
only two hours. C The cho1Δ/Δ mutant was incubated with ß-defensin or a mock challenge and
then viable CFUs were measured. No values were statistically significant from one another.
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Figure 2.7. The cho1Δ/Δ mutant elicits TNFα from macrophages in a Dectin-1-dependent
manner. A The TNFα-specific ELISA was used to measure TNFα elicited from RAW-BLUE
macrophages (Invitrogen) in response to C. albicans challenge after 4 hours. Pre-treatment with
anti-Dectin-1 neutralizing antibody reveals that the TNFα response is Dectin-1 mediated. B The
cho1Δ/Δ mutant was more efficiently phagocytosed by RAW-BLUE macrophages in comparison
to wild type and other strains.
* p-value < 0.0001
† p-value < 0.05
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Chapter III: The loss of de novo phosphatidylserine and phosphatidylethanolamine
results in reduction of the adhesin Als3p and downstream virulence factors
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Abstract
The Candida albicans mutants cho1∆/∆ (phosphatidylserine synthase) and psd1∆/∆
psd2∆/∆ (phosphatidylserine decarboxylase) are avirulent in a mouse model of systemic
candidiasis. In this chapter, we find that the mutants are also avirulent in a mouse model of
oropharyngeal candidiasis (OPC). Given that the cho1∆/∆ mutant has cell wall defects and ß(13)-glucan unmasking (explored in Chapter II) but the psd1∆/∆ psd2∆/∆ mutant did not indicated
that there may be other phenotypes more associated with a loss of offensive virulence factors.
There a variety of cell wall proteins expressed by C. albicans that are important for
virulence in the oropharyngeal candidiasis (OPC) model. One of these proteins is Als3p, an
adhesin that binds to cadherins, promotes attachment to epithelial and endothelial cells and
induces endocytosis and tissue damage. The mutants were examined for defects in Als3p and it
was found that both mutants poorly expressed Als3p on the cell surface. This correlated with
defects in adhesion to epithelial cells as well as endocytosis by, and damage to, epithelial cells.
Interestingly, the mutants did not show defects in other adhesins like Als1p or Hwp1p,
suggesting a specific regulation of the adhesin Als3p.
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The mouse model of oropharyngeal candidiasis, which includes the mouse model and histology
were performed by Norma Solis in Dr. Scott Filler’s lab. Dr. Filler also provided us with FaDu
cells. Quantification of immunofluorescence LUTs were performed by Dr. Steven Minkin. The
rest of the experiments were performed by Dr. Sarah Davis. Adhesin antibodies Als1, Als3,
Als4, and Hwp1 were a donation from Dr. Lois Hoyer.
Introduction
Als3p is an adhesin that belongs to the Als adhesin family of C. albicans and is
expressed exclusively on hyphal C. albicans (1, 60, 138-140). Adhesins play a key role in
epithelial cell adhesion, which is a key feature in the establishment and progression of
Oropharyngeal Candidiasis (OPC) (141-143). Als3p mediates adhesion by binding cadherins on
the surface of epithelial and endothelial cells (31, 66). This binding induces endocytosis,
enabling the hyphae to enter the host tissue and cause damage. When ALS3 is knocked out C.
albicans has a reduced ability to attach to oral epithelial cell lines and cause tissue damage in
mice (31, 62).
The de novo pathway for synthesizing the phospholipids phosphatidylserine (PS) and
phosphatidylethanolamine (PE) is required for the virulence of C. albicans in a mouse model of
systemic Candidiasis (44). The first step of the de novo pathway (Fig 1.2), carried out by the PS
synthase Cho1p, which generates PS from cytidyldiphosphate-diacylglycerol (CDP-DAG) and
serine, is responsible for synthesizing all PS within the cell. PS is also a substrate for PE,
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where the PS is decarboxylated by the PS decarboxylase enzymes Psd1p and Psd2p. When
Cho1p or both Psd1p and Psd2p are knocked out, there is a comparable loss of PE to about
half of wild type levels (44). The remaining PE is synthesized via the Kennedy pathway from
diacylglycerol (DAG) and ethanolamine that is primarily imported from the environment (Fig.
1.2). In fact, the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants are ethanolamine auxotrophs that
cannot make sufficient PE via the Kennedy pathway without importing ethanolamine.
Here we describe how loss of PE synthesis through PS synthase (cho1∆/∆) or PS
decarboxylase (psd1∆/∆ psd2∆/∆) mutations results in a reduction in Als3p and Als3passociated virulence phenotypes such as epithelial adhesion and damage.
Results
The cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants exhibit cell wall defects (44). As PE is the
donor for ethanolamine-phosphate moieties required for glycosylphosphatidylinositol (GPI)
anchor synthesis (82, 144), we hypothesized that this may lead to poor expression of GPIanchored proteins at the cell surface of hyphae. Many cell wall adhesins are GPI-anchored
proteins, so we assessed whether GPI-anchored adhesins associated with hyphae were
compromised in the mutants compared to wild-type using monoclonal antibodies. Analysis of
the Als3p expression on the cell surface was assessed by immunofluorescence, revealing that
the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants exhibit lower levels of Als3p on hyphae, with the
lowest levels of fluorescence associated with the cho1∆/∆ mutant (Fig. 3.1 A). In addition, there
were fewer cho1∆/∆ and psd1∆/∆ psd2∆/∆ cells expressing detectable Als3p compared to wildtype (Fig. 3.1 B). These original findings support our hypothesis that a loss of PE would
ultimately result in a loss of GPI anchored proteins. The loss of Als3p suggested the possibility
that other GPI-anchored adhesins were also diminished in hyphae, which may help explain
decreased virulence and unmasking reported in chapter II. However, examination of Als1p,
Als4p, and Hwp1p using immunofluorescence revealed no differences between strains (Fig. 3.2
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A & B & data not shown). This suggested that the Als3p expression defect is not due to a
general defect in GPI-anchored protein processing or hyphal protein distribution, but a
consequence of reduced Als3p expression.
As Als3p expression is associated with adhesion to mammalian cell lines, we tested if
the loss of Als3p expression would correlate with a loss in adhesion to the Chinese hamster
ovary (CHO) cell line, which is used as an in vitro model for epithelial cell adhesion. It was
found that the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants both exhibit reduced adhesion to CHO
cells (Fig 3.3), which is correlated with the decrease they exhibit in Als3p expression (Fig. 3.1 A
& B).
Als3p acts as an invasin that induces endocytosis of C. albicans hyphae into cell lines
that express cadherins, such as FaDu oral epithelial lines, and mutants that lack ALS3 have
decreased endocytosis (31). When C. albicans strains are co-incubated with the FaDu cells,
the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants show reduced endocytosis (Fig 3.4 A). C. albicans
cells that have been endocytosed can subsequently damage epithelial cells which can be
measured by the level of lactate dehydrogenase (LDH) released into the media. As predicted,
the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants have lower LDH released into the media (Fig 3.4 B).
Als3p is not required for virulence in a systemic model of infection (71), however it has
been shown to play a minor role in OPC (145). In order to investigate if the cho1∆/∆ and
psd1∆/∆ psd2∆/∆ mutants exhibit a loss of virulence in oropharyngeal infection, a mouse model
of OPC was performed (146). There was a decrease in pathogenicity for both the cho1∆/∆ and
psd1∆/∆ psd2∆/∆ mutants in OPC infections (Fig. 3.5 A & B). The cho1∆/∆ and psd1∆/∆
psd2∆/∆ mutants both showed decreased colonization of the tongues of mice based on
recovered colony forming unit counts (CFUs). The mutants also had decreased levels of
colonization on the epithelium as can be seen by histology (Fig 3.5 C).
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Discussion
ALS3 expression is controlled by phospholipid levels
The cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants have both a qualitative and quantitative
decrease in the adhesin Als3p (Fig. 3.1 A & B), which is a virulence factor in the mouse model
of OPC (145). Loss of Als3p results in a decrease in adhesion to CHO and FaDu cell lines,
which correlates with a loss in damage to, and endocytosis by, epithelial cells (Fig. 3.4 A & B). It
is important to note that this decrease is specific to Als3p, and there are no deficiencies in the
immunofluorescence of other adhesins such as Als1p and Als4p (Fig. 3.2 A & B). This led us to
believe that decreased PE results in a reduction of Als3p immunofluorescence, and this
reduction is more prominent when PS as well as PE are reduced in the cho1∆/∆ mutant.
We hypothesize that the loss of these phospholipids affects signal transduction cascades that
control the regulation of Als3p. We currently do not know which pathways are involved. One
pathway known to be important in the specific Als3p regulation is the pH sensing pathway which
is mediated by the transcription factor Rim101. This is dependent on proteolytic cleavage and
activation of Rim101 in response to neutral pH in a cascade that depends on endosomal
trafficking components (147-152). However, Western blots comparing our mutants to wild type
showed that there are no differences in Rim101p processing in these strains (Fig. 3.6). It is
important to note that there may be other pathways dependent on PS and/or PE that are
regulating ALS3 expression. For example, Protein kinase C (Pkc1p) in the cell wall integrity
MAP kinase pathway depends on PS in S. cerevisiae (66).
Materials & Methods
Strains and media
The C. albicans strains used in this study are in Table 1. The media used for most
experiments for growth and maintenance of the strains was YPD (yeast extract, peptone, and
dextrose) liquid media and plates. For growth curves, we used minimal media (yeast nitrogen
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base, dextrose) ± ethanolamine. The AtSDC strains were generated as follows: First, the
AtSDC gene was codon optimized by site-directed mutagenesis in the yeast expression vector
pVT103-U (153), and was then PCR amplified with SDO17 and SDO18 which introduced NcoI
and BglII sites that were used to replace the dTomato gene found between these sites in the
pENO-dTomato-NATr plasmid (154), creating the plasmid pENO1-AtSDC. This plasmid was
linearized with EcoRV, and then transformed by electroporation as previously described (44).
Generation of the Rim101-V5 strains
Rim101p was tagged with V5 in our strains using the pYLC314.1-RIM101-V5 plasmid,
which was created as follows. A vector carrying the SAT1 marker, pYLC314, was created first.
pYLC314 was created from pBluescript II SK+ by cutting it with EcoRI and ligating into it a 1.7kb
fragment containing the SAT1 marker followed by the C.albicans MET3 promoter. This
fragment was generated by PCR from pYLC229 (155) using primers JCO165 and JCO166 that
introduced EcoRI sites on both flanks (see Table 2). The MET3 promoter was removed by
cutting pYLC314 with PstI, which cut on either side of the MET3 promoter and then re-ligating to
create pYLC314.1. The C. albicans RIM101 gene, plus 1000 base pairs (bps) of upstream DNA
and 240 bps downstream, was amplified with primers TRO892 and TRO893, which introduced
ApaI and XhoI sites respectively, and was cloned into plasmid pYLC314.1 to create pLYC314.1RIM101; for primer sequences see Table 2. A V5 epitope tag was added to RIM101 at the
internal AgeI site (147) by digesting the plasmid with AgeI and BstBI to remove a segment of
RIM101, which was replaced by a fragment that was identical except that a V5 tag was added
just after the AgeI site. This was done by amplifying the RIM101 sequence with primers SD22,
which introduced the V5 tag, and SDO20. pYLC134-RIM101-V5 was linearized with BstBI and it
was transformed into C. albicans strains by electroporation (135).
Endocytosis of Candida albicans into epithelial cells
Endocytosis was measured as previously described (31).
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LDH Release
The day prior to the experiment, FaDu cell were plated at 5*105 cells/well in a 24 well
plate in HBSS media + 10% FBS. The next day, media was replaced with fresh HBSS + 2%
human serum. C. albicans cells were added to wells at an M.O.I. of 5 and co-incubated for 6
hours at 37ºC + 5% CO2. At this time supernatant was harvested and LDH release was
quantified using the CytoTox 96 Non-Radioactive Cytotoxicity Assay (Promega, Cat# G1782).
Adhesion Assay to epithelial cells
The day prior to the experiment, 4*105 Chinese hamster ovary (CHO) cells/well were
plated in a 6 well plate with F12 media + 10% FBS + penicillin/streptomycin. The next day, 6*105
C. albicans cells from an overnight culture grown in YPD were washed 3X with 1mL of PBS and
resuspended in 9mL complete F12 media in a glass test tube. These were incubated at 37°C for
1 hour in the shaking incubator. After 1 hour, media was removed from the CHO cells and 3 mL
of the F12 yeast mixture were added to each well. These plates were returned to 37°C and
incubated for 2 hours (no shaking). After incubation, media was removed from the wells which
were washed 5X with 3 mL PBS. Once washing was complete, 3mL of water was added to each
well in order to lyse the CHO cells. After 10 minutes, the bottom of the plates were scraped with
a cell scraper to release remaining Candida. This cell mixture was then diluted 1:10, then 100 µl
of diluent was plated onto YPD + 1M sorbitol plates and incubated overnight at 37°C for 24
hours. Colony forming units were then counted to determine CFU/ml.
Western Blot for Rim101p-V5 detection
Overnight cultures were diluted to 0.1 OD in 50 mL YPD and incubated for 3 hours in
30°C shaking incubator. After 3 hours, cells were stimulated with M199 media at a pH of 8 for
30 minutes in 30°C shaking incubator. After stimulation cells were pelleted by centrifugation at
3300rpm for 3 minutes then the pellet was resuspended in 250 µl PBS with protease inhibitors
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(Roche cat# 4693124001) and bead beaten 3 times for 30 seconds each. Samples were spun
down at 2000rpm and the supernatant was measured by Bradford and resuspended in Laemmli
loading buffer. 20µg protein was run on an 8% acrylamide gel and transferred to PVDF
overnight. Blocking was 1 hour in TBST + 5% milk, primary was 1:2000 dilution of V5 antibody
conjugated to HRP (Abcam cat# ab1325) overnight. After primary, the blot was washed 3X
quickly with TBST then 2X at 5 minutes each with TBST. Western blot was developed with
Supersignal West Pico Chemiluminescent Substrate (Thermo Scientific cat # 34080).
Oropharyngeal Candidiasis Model
This experiment was adapted from a previous publication (145, 146).
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Appendix. Chapter III Figures

Figure 3.1. Mutants reduced in virulence are diminished in Als3p. A The cho1∆/∆ and
psd1∆/∆ psd2∆/∆ mutants are reduced in Als3p measured by immunofluorescence. B
Quantification of the number of cells in the population with detectable Als3p. * Comparing WT to
cho1∆/∆, p-value < 0.0005

** Comparing WT to psd1∆/∆ psd2∆/∆, p-value <0.005
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A

B

Figure 3.2. The Als1p (A) and Als4p (B) adhesins are expressed equally among the
phospholipid mutants and wild type.
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Figure 3.3. Loss of Als3p correlates with a loss of adhesion to the CHO cell line. The
cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants are both reduced in the ability to attach to mammalian
epithelial cells. * p-value< 0.0001 compared to WT.
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Figure 3.4. Mutants reduced in Als3p are also reduced in ability to induce endocytosis
and tissue damage. A After co-incubation of C. albicans with FaDu cells and then
counterstaining to visualize endocytosis, it was shown that for the cho1∆/∆ and psd1∆/∆
psd2∆/∆ mutants there is a reduction in endocytosis by the epithelial cell line. B The cho1∆/∆
and psd1∆/∆ psd2∆/∆ mutants are both reduced in their ability to cause damage to the FaDu
cells, indicated by the reduction in lactase dehydrogenase (LDH) release. * p-value< 0.005,

†

p-

value< 0.05, ** p-value< 0.0005 †† p-value< 0.001, all compared to WT.
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Figure 3.5. The cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants are attenuated for virulence in
OPC in mice. A, B. Mice were inoculated orally with C. albicans strains, and after five days,
their tongues were harvested, and the CFUs/gram of tissue were measured. C. PAS (periodic
acid-Schiff) staining of histological samples from a clipping of tissue from tongues in A and B is
shown for each strain. * = P-value < 0.0002, Compared to WT.
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Figure 3.6. There are no differences in the proteolytic processing of the Rim101p
transcription factor. Activation of the Rim101p transcription factor is the same for all strains,
indicating that Als3p regulation is mediated by another means. YPD is a neutral pH of 6.7 and
does not activate the pathway. “8” in the figure denotes M199 media adjusted to the pH 8 which
activates Rim101p proteolytic cleavage.
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Chapter IV: Ethanolamine auxotrophy is responsible for avirulence in the cho1∆/∆ and
psd1∆/∆ psd2∆/∆ mutants
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Abstract
Candida albicans null mutants in the de novo synthesis of phosphatidylserine (cho1∆/∆
mutant) and phosphatidylethanolamine (psd1∆/∆ psd2∆/∆ mutant) are greatly reduced in
virulence in both a systemic infection model and an oropharyngeal model of Candidiasis. The
cho1∆/∆ mutant is unable to synthesize phosphatidylserine (PS) and is reduced in
phosphatidylethanolamine (PE), whereas the psd1∆/∆ psd2∆/∆ mutant is only diminished in PE
and has elevated levels of PS. Due to the loss of the de novo pathways, both mutants are
ethanolamine auxotrophs. It was unclear if ethanolamine auxotrophy was the major contributor
to this loss of virulence, or whether the attenuation in virulence was due to cell wall defects or
cell signaling.
In order to delve into what factors were contributing to avirulence, we tested the
hypothesis that the main defect in virulence was because on an inability to grow in the host due
to ethanolamine auxotrophy. These mutants require 1mM ethanolamine in culture media for
growth and host ethanolamine is estimated at ~30µM. This hypothesis was tested by supplying
ethanolamine to the mutants through expression of the Arabidopsis thaliana serine
decarboxylase (AtSDC), which converts cytoplasmic serine to ethanolamine for PE synthesis by
the Kennedy pathway. The AtSDC completely restored ethanolamine prototrophy and virulence
in the mice, indicating that ethanolamine auxotrophy is the main cause of avirulence in cho1∆/∆
and psd1∆/∆ psd2∆/∆ mutants.
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Introduction
The de novo pathway for synthesizing the phospholipids phosphatidylserine (PS) and
phosphatidylethanolamine (PE) is required for the virulence of C. albicans in a mouse model of
systemic Candidiasis (44). The first step of the de novo pathway, carried out by the PS synthase
Cho1p, is responsible for synthesizing all PS within the cell. This PS is also a substrate for PE in
the de novo pathway, where the PS is decarboxylated by the PS decarboxylase enzymes
Psd1p and Psd2p (Fig. 1.2). When Cho1p is knocked out (the cho1∆/∆ mutant) or both Psd1p
and Psd2p are knocked out (the psd1∆/∆ psd2∆/∆ mutant), there is a comparable loss of PE by
about half of wild type levels (44).
Both the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants are ethanolamine auxotrophs, and
cannot grow in minimal media without ethanolamine (44). It was unclear whether this
auxotrophy is the major contributor to the loss of virulence, or whether the loss of PS and/or PE
resulted in other problems (i.e. cell signaling, cell wall perturbations) that would be the major
contributor to virulence. These were of concern due to the fact that the cho1∆/∆ mutant exhibits
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cell wall defects that results in ß-(1,3) glucan exposure and elicitation of TNFα from
macrophages, which could at least play a part in immune activation and elimination in vivo (83).
Due to the fact that the psd1∆/∆ psd2∆/∆ mutant does not have cell wall defects, but has
reduced PE levels comparable to the cho1∆/∆ mutant and is avirulent, we suspected that an
inability to acquire sufficient ethanolamine in vivo to synthesize PE via the Kennedy Pathway
could be a major contributor to the inability to survive in the host. In order to assess survival, we
performed short-term assays an in vitro measure of hyphal length generation in human serum,
as well as an in vivo mouse experiment (Fig 2.2). These assays revealed that at least for a short
period of time the mutants were able to generate hyphae. However, we later speculated that
hyphal generation could be due to the cell using ethanolamine that had been stored in the cell
and did not reflect what would occur during a long-term infection. Therefore our goal was to
determine whether the mouse could provide enough ethanolamine to the cho1∆/∆ and psd1∆/∆
psd2∆/∆ mutants to support growth.
In order to investigate this question, we increased levels of endogenous ethanolamine
by addition of the Arabidopsis thaliana serine decarboxylase gene, which decarboxylates serine
to ethanolamine (Fig. 1.2). This ethanolamine can then be used by the Kennedy pathway to
generate PE (Fig. 1.2). With this new means of making PE, the virulence of Candida albicans
was restored for both the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants in a mouse model of systemic
infection. This suggests that our attenuated mutants are unable to acquire sufficient levels of
ethanolamine inside the host during infection, resulting in an inability to proliferate and cause
disseminated disease. Altogether our findings indicate that PE is a virulence factor of C.
albicans that can be targeted potentially by targeting activity of the Cho1p (phosphatidylserine
synthase) enzyme, reducing virulence and making Cho1p an excellent drug target.
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Results
Loss of de novo PE synthesis compromises virulence through ethanolamine auxotrophy
The cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants share a comparable loss in PE and are both
ethanolamine auxotrophs (44), so we hypothesized that the reason for the loss of virulence is
due to an inability to acquire sufficient amounts of ethanolamine for PE synthesis by the
Kennedy pathway within the host. The level of ethanolamine in the host is estimated to be
~30µM, but the level required to support growth in culture media is greater than 100µM (44,
156). A full understanding of how the loss of PS and de novo PE contribute to avirulence and
interfere with host-pathogen interactions will aid in the development of assays to search for
future inhibitors that can be used in drug development, or will reveal other alternative drug
targets which may also be exploited.
In order to test this hypothesis, a serine decarboxylase enzyme derived originally from
Arabidopsis thaliana (AtSDC) was expressed in our C. albicans strains after codon optimization
(153, 157). AtSDC decarboxylates serine to ethanolamine within the cytoplasm, and the
ethanolamine can then be used by the Kennedy pathway to synthesize PE (Fig. 4.1). If
ethanolamine auxotrophy is mediating the loss of virulence, addition of this enzyme should
restore ethanolamine prototrophy and virulence in a mouse model of systemic Candidiasis.
The ability of AtSDC to restore ethanolamine prototrophy in the cho1∆/∆ and psd1∆/∆
psd2∆/∆ strains was tested by measuring growth in minimal media +/- ethanolamine (Fig. 4.2 A
& B). As expected, the mutants that exhibited ethanolamine auxotrophy in the past were unable
to grow in the absence of ethanolamine. When grown in media lacking ethanolamine, the
transformed mutants expressing AtSDC grew at rates similar to the respective parental mutant
strains in the presence of ethanolamine (Fig. 4.2 A & B). In addition, thin layer chromatography
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(TLC) confirmed that PE levels were restored in the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants
when AtSDC is expressed, even when grown in the absence of ethanolamine (Fig. 4.2 C).
We then examined if addition of AtSDC would restore virulence for the cho1∆/∆ and
psd1∆/∆ psd2∆/∆ mutants in a mouse model of systemic infection (Fig. 4.3 A & B). Indeed, the
addition of this enzyme fully restored virulence to both the cho1∆/∆ and psd1∆/∆ psd2∆/∆
mutants in the systemic infection model. The differences seen for the survival curve were
reflected in fungal burden measurements (Fig. 4.3 C). Although it not clear what is directly
responsible for this, it is interesting to note that although both the cho1∆/∆ and psd1∆/∆ psd2∆/∆
mutants had much lower fungal burden than wild-type, the cho1∆/∆ mutant is diminished more
than the psd1∆/∆ psd2∆/∆ mutant (Fig. 4.3 C). This may be attributable to the diminished Als3p
expression, increased unmasking, or both.
The Role of Kennedy pathway PE in regulating Als3p and cell wall unmasking
As Als3p is diminished for both the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants, it seemed
likely that PE levels were important for this regulation. Therefore, Als3p levels were analyzed
by immunofluorescence for the wild-type and mutant strains expressing AtSDC. The addition of
the AtSDC increases Als3p for the psd1∆/∆ psd2∆/∆ mutant, but not the cho1∆/∆ mutant (Fig.
4.4 A). Relative mean intensity reveals that for Als3p staining, the cho1∆/∆ and cho1∆/∆-AtSDC
mutants exhibit comparable intensity, while psd1∆/∆ psd2∆/∆-AtSDC is more similar to wild type
in levels (Fig. 4.4 E). However, the adhesion to CHO cells seems to be restored for both the
cho1∆/∆-AtSDC and psd1∆/∆ psd2∆/∆-AtSDC (Fig. 4.4 B). The cho1∆/∆ mutant exposes more
ß-(1,3) glucan than wild-type in both yeast and hyphal forms, which leads to increased
recognition by innate immune cells (83). This effect appears to be mediated solely by the loss of
PS, as we did not see rescue of ß-(1,3) glucan unmasking in the cho1∆/∆ mutant by addition of
AtSDC for either the yeast or the hyphae (Fig. 4.4 C & D). As Als3p is a known virulence factor
for the development of orophyrangeal candidiasis (OPC), we tested the in vivo mouse model to
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determine if addition of the AtSDC gene would affect virulence (31, 63). When the cho1∆/∆AtSDC and the psd1∆/∆ psd2∆/∆-AtSDC mutants were tested in this model, virulence was
restored and there were no statistical differences between these strains and wild type (Fig. 4.5).
Discussion
Virulence defects in the cho1∆∆ and psd1∆∆ psd2∆∆ mutants are primarily the products of
ethanolamine auxotrophy
The cho1∆/∆ and psd1∆∆ psd2∆/∆ mutants exhibit a number of phenotypes, but the
cho1∆/∆ mutant has more substantial cell wall defects than the psd1∆/∆ psd2∆/∆ mutants,
including greater exposure of ß-(1,3) glucan, and loss of Als3p than psd1∆/∆ psd2∆/∆ (83). This
has repeatedly raised the question of whether the losses of virulence observed for the cho1∆/∆
or psd1∆/∆ psd2∆/∆ mutants are due more to deficiencies in synthesis of PS and PE, or PE
alone. The PE synthesis defect is the primary culprit, as both mutants share this in common,
and the mutants require a minimum of 1mM ethanolamine for growth in culture media and the
level of ethanolamine in the host is only ~30 µM (44, 156). The observation that AtSDC can
suppress Als3p expression defects in psd1∆/∆ psd2∆/∆, but not cho1∆/∆ suggests that both PE
and PS independently regulate Als3p, a surprising and interesting finding.
In order to address whether an inability to acquire PE is the result of avirulence for C.
albicans mutants in the mouse model of disseminated candidiasis, we first heterologously
expressed in C. albicans the AtSDC, which decarboxylates serine into ethanolamine in the cell’s
cytoplasm (153). This ethanolamine can then be used by the Kennedy pathway to create PE
(Fig. 1.1 & 4.1). If virulence is restored for both mutants expressing AtSDC, then this shows that
insufficient PE synthesis in the host environment due to an inability to acquire enough
ethanolamine substrate is the main contributor to avirulence. Synthesis of ethanolamine by
AtSDC supported growth of the mutants in culture media to levels similar to when they are
supplemented with 1mM ethanolamine (Fig. 4.2 A & B) and also restored PE levels (Fig. 4.2 C).
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Finally AtSDC restored virulence in the systemic mouse model based on survival curves and
fungal burden, and also restored virulence in the OPC model (Fig. 4.3 & 4.5).
Materials and Methods
Immunofluorescent Staining of hyphae
This protocol was modified from a previous publication (83). It is important to note that
hyphae were induced for AtSDC strains with mouse serum rather than human serum.
Quantification of Immunofluorescence
Quantification of LUT’s were performed as previously described (83).
Immunofluorescence staining for ß-(1,3) glucan
The method from Davis et al (83) was used, and stationary cultures were stained.
Hot ethanol extraction and TLC
Sample extraction and TLC protocols were performed as previously described (44) with
the following exceptions. Before running with samples, TLC silica gel plates (Fisher cat#
M1057290001) were prepared by baking them in a drying oven at 100°C for 15 minutes. After
baking, these plates were run with 50mM EDTA. Plates were then run with a chloroform:
methanol (1:1) migration solvent to remove EDTA, dried, and baked in the oven again for 15
minutes. The samples were then loaded and run as described. Lipids were visualized on the
dried plate by spraying with Primuline dye (5mg of Primuline, cat# 206865, Sigma, in 100ml of
acetone: and visualizing with UV light.
Mouse systemic infection model
To prepare strains for injection, 1 O.D. from overnight test tube cultures were washed 5
times with 1 mL ddH2O then counted by hemacytometer. These washed cultures were then
diluted to 5*106 cells/ml and 100 µl of cell solution was injected into ICR (Harlan) mice for a total
of 5*105 yeast/mouse. N=5 mice for each Candida strain. An animal protocol on file with the UT
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IACUC ensures humane treatment of the animals. For fungal burdens, cultures were prepared
and injected the same way as they were for the mouse mortality assay described above. 5 days
after injection, mice were humanely euthanized, and then both kidneys were removed, one for
histology and one for CFU counts. The kidney for histology was stored in 10% formaldehyde
and later sections and stained with H&E by the University of Tennessee Veterinary School. The
other kidney was weighed and homogenized with a dounce homogenizer in 5 ml ddH2O. This
homogenate was diluted 1:4 and 200 µl was plated on YPD + 1M sorbitol plates for CFU counts.
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Appendix. Chapter IV Figures

Figure 4.1. Pathways for synthesizing phosphatidylethanolamine in C. albicans. The
Kennedy pathway genes are shown in gray, and are named after their predicted homologs in S.
cerevisiae, and the de novo pathway proteins are shown in white. Arabidopsis thaliana Serine
Decarboxylase (AtSDC) is shown in black. Eth: ethanolamine, Cho: choline, Eth-P:
phosphoethanolamine, Cho-P: phosphocholine, Etn-CDP: cytidyldiphosphate-ethanolamine,
Cho-CDP: cytidyldiphosphate-choline, PS: phosphatidylserine, PE: phosphatidylethanolamine,
PC: phosphatidylcholine, CDP-DAG: cytidyldiphosphate-diacylglycerol, Ser: serine.

63

Figure 4.2. Expression of AtSDC restores ethanolamine prototrophy and virulence in
cho1∆/∆ or psd1∆/∆ psd2∆/∆ in a mouse model of disseminated candidiasis. A,B Mutant
and wild-type (WT) strains ± AtSDC were grown in minimal media ± ethanolamine (Eth) and a
growth curve was plotted using OD600 measurements. C Phospholipids were isolated from
each strain grown in minimal media lacking ethanolamine, and then separated by TLC. They
were visualized with primuline stain under ultraviolet light.
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Figure 4.3. Expression of AtSDC restores virulence in cho1∆/∆ or psd1∆/∆ psd2∆/∆ in a
mouse model of disseminated candidiasis. A, B.. Mice were infected by tail-vein with 5x105
cells from each strain and survival was charted over time. C Mice were infected with 5x105 cells
by tail-vein and after five days, they were sacrificed, and kidneys were removed, and
CFUs/gram kidney were counted. * P-value < 0.05, Compared to WT. † P-value <-.05,
Compared to psd1∆/∆ psd2∆/∆.
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Figure 4.4. AtSDC restores phenotypes in the psd1∆/∆ psd2∆/∆ mutant, but not cho1∆/∆.
A The mutant and control strains were induced to form hyphae by serum, and Als3p was
examined by secondary immunofluorescence using a monoclonal antibody to Als3p as the
primary. B The AtDSC expressing strains were tested for adhesion to CHO cells in tissue
culture. C The cho1∆/∆ mutant and cho1∆/∆-AtSDC mutant was stained for ß-(1,3) glucan
exposure with the anti-ß(1-3)-glucan antibody on yeast form. D The cho1∆/∆ mutant and
cho1∆/∆-AtSDC mutant was stained for ß-(1,3) glucan exposure with the anti-ß(1,3)-glucan
antibody on hyphal form. E Quantification of Als3p by measuring relative intensity shows Als3p
levels restored for the psd1∆/∆ psd2∆/∆-AtSDC mutant but not the cho1∆/∆-AtSDC mutant.
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Figure 4.5. Addition of the AtSDC gene restores virulence in the cho1∆/∆ and psd1∆/∆
psd2∆/∆ mutants expressing the serine decarboxylase. There are no statistical differences
between wild type (WT), cho1∆/∆-AtSDC or psd1∆/∆ psd2∆/∆-AtSDC.
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Chapter V: Conclusions and Future Directions
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Conclusions of Dissertation
Altogether, the findings in this dissertation illustrate how a loss of phosphatidylserine
(PS) for Candida albicans via the avirulent cho1∆/∆ mutant results in perturbations in the cell
wall, ultimately resulting in disturbances in the surface which enables ß-(1,3) glucan to become
exposed on the surface. This polysaccharide can then be recognized by effector cells such as
macrophages and neutrophils in the host, eliciting an immune response. This is a novel
phenomenon showing a link between phospholipid synthesis and cell wall construction and/or
maintenance.
In addition to a loss of PS, the cho1∆/∆ mutant is reduced in phosphatidylethanolamine
(PE) levels, a relatively abundant phospholipid. Ultimately the question was to determine
whether a loss of virulence for the cho1∆/∆ mutant was due to a loss of PS or PE. In order to
address this, there was a double mutant generated that could not synthesize de novo PE, which
was the psd1∆/∆ psd2∆/∆ mutant. This mutant was also avirulent, suggesting that PE was
important for virulence. Since the cho1∆/∆ mutant was shown to have cell wall defects, we
speculated that this would lead to differences in proteins on the cell surface that may play a role
in virulence. However studies of these proteins revealed that this may not be the case, although
there is a difference in the Als3p adhesin protein and a reduction in the oropharyngeal
candidiasis (OPC) model for both the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants.
Although the psd1∆/∆ psd2∆/∆ mutant was avirulent, it was unclear if it was due to
difficulty with acquiring ethanolamine in the host or if it’s Kenney Pathway was simply
insufficient to incorporate cellular ethanolamine into PE. By adding the Serine Decarboxylase to
the strains we were able to reveal that the Kennedy Pathway is more than sufficient to support
PE synthesis and thus restoring virulence for both the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants,
showing us that the mechanism behind the loss of virulence in these phospholipid synthesis
mutants is ultimately due to lack of ethanolamine inside the host.
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Future Directions
Chen et al. discovered that there are significant cell wall aberrations in the cho1∆/∆
mutant, but it is unclear how a loss of phospholipids results in cell wall perturbation. It is also
interesting to note that this phenomenon only seems to occur with the cho1∆/∆ mutant but not
as much with the psd1∆/∆ psd2∆/∆ mutant, yet both are avirulent and have phospholipid
deficiencies, suggesting that the loss of phosphatidylserine is specifically responsible for most
cell wall issues. Our current hypothesis is that the loss of phosphatidylserine affects cell
signaling beginning at cell surface receptors, ultimately resulting in downstream transcriptional
regulation that regulate cell wall synthesis.
There is ample evidence suggesting that the problems that the cho1∆/∆ mutant has with
cell wall integrity as well as temperature and osmolarity sensitivity (44) are mediated by
complications of signaling pathways. Data that supports this hypothesis is a western blot
showing the high osmolarity pathway (HOG pathway) being constitutively activated in the
cho1∆/∆ mutant but becomes reduced when supplemented with sorbitol, which helps to stabilize
osmolarity outside of the cell (Fig. A5) (44). This finding correlates with data previously
generated in our lab, with the cho1∆/∆ mutant having poor growth in regular YPD media but is
restored when sorbitol is added to the media (44). The HOG pathway as well as the cell wall
integrity (PCK) pathway are also implicated in cell wall stress, which can be activated by
osmolarity stress (158). Interestingly, our western blots reveal that the Pkc1p-mediated pathway
is constitutively activated for the cho1∆/∆ mutant and does not seem to be rescued with any
addition of sorbitol, which may indicate other factors are at play (Fig. A5). Additionally, the PKC
pathway can be activated by caspofungin which induces cell wall stress. When the strains are
stimulated, we see once again that the cho1∆/∆ mutant is constitutively activated but no other
strains are (Fig. A6). Additionally, under caspofungin stimulation the Hog1p seems to
phosphorylate less for the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants than the wild type, suggesting
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that there may be some inverse relationship between activation of the PKC1 and Hog1
pathways (Fig. A6). Other pathways that may be involved include the CEK pathway, which is
also known to regulate cell wall reconstruction by regulating the switch from yeast to filamentous
growth (113, 159). The Cek1p pathway regulates this filamentation by regulation of the GTPase
Cdc42p, which when active is polarized to the hyphal tip to promote elongation. (113). In
Saccharomyces cerevisiae, the cho1∆/∆ mutant has a deficiency in Cdc42p polarization, leading
to delayed bud formation (160). Due to the fact that the cho1∆/∆ mutant has a complete lack of
PS, the Cdc42p may have difficulties localizing to the proper location on the membrane. We
have some preliminary evidence that the cho1∆/∆ mutant does not have Cdc42p polarized to
the hyphae, which also coincides with the cho1∆/∆ mutant developing hyphae slower than our
other strains in certain growth conditions (44).
Cdc42p has a sequence of 4 lysine residues near the C-terminus, lending it a general
positive charge on its surface (161). This positive charge may have interactions with the PS
located on the inner leaflet of the cell membrane, assisting in co-localization between the PS in
the membrane of the emerging hyphae and Cdc42p. In order to determine whether Cdc42p mislocalization is influencing the cell wall architecture of the cho1∆/∆ mutant, a Cdc42p mutant can
be designed with targeted mutations in the important Lysine residues, changing them to a less
positively charged amino acid (such as aspartic acid). This would potentially mimic the absence
of PS in an otherwise wild-type cell. Alternatively, a hyperactive allele of Cdc42p, when
expressed in C. albicans may restore localization in the cho1∆/∆ mutant. If localization is
restored, the cell wall phenotype of the constitutive mutant will be observed by electron
microscopy, ß-(1,3) glucan staining and SDS and caspofungin treatment. If Cdc42p also plays a
role in any cell signaling, Mkc1p activation and Hog1p activation can be tested by western blot.
However, it is possible that mutations in the Lysine-containing motif do not affect Cdc42p
localization and its downstream effects. If this is the case, an alternative approach would be to
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transform a hyper-active Ste11 into the cho1∆/∆ mutant (162). Ste11 is a Mitogen Activated
Protein Kinase Kinase Kinase (MAP-KKK) that is activated downstream of Cdc42p, and if active
can circumvent the issues with Cdc42p localization (163). If addition of this hyper-active Ste11p
allele by transformation into the cho1∆/∆ mutant reduces cell wall perturbations and sensitivity, it
would indicate that the Cek1p pathway is involved.
As the cho1∆/∆ mutant is also the only mutant that we have discovered to have
increased exposure of ß-(1,3) glucan, future directions will be conducting a large scale
screening of mutants in various signaling pathways to determine if there are other mutants that
have this exposure of ß-(1,3) glucan, which would provide stronger evidence that there are
signaling pathways at play.
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Table 1. Candida albicans strains
Strain

Parent

Genotype

Source of Ref.

SC5314

Clinical isolate

Prototrophic Wild Type

(164)

YLC337

cho1Δ/ cho1Δ

(44)

YLC344

cho1Δ/cho1Δ::CHO1-SAT1

(44)

YLC280

psd1Δ/ psd1Δ

(44)

YLC294

psd1Δ/ psd1Δ::PSD1-SAT1

(44)

YLC375

psd2Δ/psd2Δ psd1Δ/psd1Δ

(44)

SED010

SC5314

Wild Type-PENO1-GFP-SAT1

This study

SED013

YLC337

cho1Δ/ cho1Δ -PENO1-GFP-SAT1

This study

SED016

YLC280

psd1Δ/ psd1Δ -PENO1-GFP-SAT1

This study

SED019

YLC375

psd2Δ/psd2Δ psd1Δ/psd1Δ
- PENO1-GFP-SAT1

This study

SED022

YLC344

cho1Δ/Δ::CHO1 with SAT1 flipped out

This study

SED024

SED022

cho1Δ/ cho1Δ::CHO1 -PENO1-GFP-SAT1

This study

SED025

SC5314

WT::Rim101-V5-SAT1

This study

SED026

YLC337

cho1∆/cho1∆::Rim101-V5-SAT1

This study

SED027

YLC280

psd1∆/psd1∆::Rim101-V5-SAT1

This study

SED028

YLC375

psd2∆/psd2∆ psd1∆/psd1∆::
Rim101-V5-SAT1

This study

SED029

YLC375

psd2∆/psd2∆ psd1∆/psd1∆::PSD1-SAT1

This study

SED030

SC5314

SC5314::AtSDC::SAT1

This study

SED031

YLC337

cho1∆/cho1∆::AtSDC::SAT1

This study

SED032

YLC280

psd1∆/psd1∆::AtSDC::SAT1

This study

SED033

YLC375

psd2∆/psd2∆ psd1∆/psd1∆
::AtSDC::SAT1

This study
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Table 2. Primers used in this study
Primer

Sequence

Use

SDO17

aaaaccatggATGGTTGGATCTTTGGAATCTGA

AtSDC plasmid

SDO18

aaaaagatctCTAGACCATGCTCCTACCTAGA

AtSDC plasmid

JCO165

aaagaattcCGTCAAAACTAGAGAATAATAAAG

Rim101p-V5 plasmid

JCO166

aaagaattcGTTTTCTGGGGAGGGTATTT

Rim101p-V5 plasmid

TRO892

AAAAGGGCCCTTTTGCATCCATAAACAGAGTACA

Rim101p-V5 plasmid

TRO893

AAAACTCGAGAGGTCAAGCTGGTGTGTTGTA

Rim101p-V5 plasmid

SDO20

GTCGTCGTAGTTCAATCC

Rim101p-V5 plasmid

SDO22

aaaaaaACCGGTGGTAAGCCTATCCCTAACCCTCTCC
TCGGTCTCGATTCTACGGCAAGTGAGAGTACTGC

.

Rim101p-V5 plasmid
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Table 3. Quantification of the Occurrence of Abnormal Hyphae in Mutants
Strain

Cells with Deformity

Cells Total

Percentage (%)

SC5314

0

37

0.00%

cho1Δ/Δ

11

23

47.83%

cho1::CHO1

0

13

0.00%

psd1Δ/Δ

0

29

0.00%

psd1::PSD1

0

19

0.00%

21

52.38%

psd1Δ/Δ psd2Δ/Δ 11
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Appendix. Additional Figures
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Figure A1. ß-(1,3) glucan and Dectin-1 co-staining immunofluorescence of yeast. Top
row panels: Brightfield optics. Midde row of panels: Staining with anti- ß-(1,3) glucan antibody
and C3 (red) conjugated secondary antibody. Bottom row of panels: Staining with sDectin-1-Fc
and C2 (green) conjugated to secondary antibody.

91

Figure A2. ß-(1,3) glucan and Dectin-1 co-staining immunofluorescence of hyphae.
Staining illustrates the co-localization of ß-(1,3) glucan staining and binding of the Dectin-1
receptor. Red = ß-(1,3) glucan. Green = Dectin-1.
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Figure A3. Hyphae co-staining is comparable between the ß-(1,3) glucan antibody and
sDectin-1-Fc. The number of hyphae for a given field of view that stained with ß-(1,3) glucan
and Dectin-1-Fc were independently divided by the total number of hyphae apparent by bright
field optics to calculate the percent stained for each fluor. N=20 per strain. “R” after strain name
denotes reintegration.
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Figure A4. ELISA of TNFα elicitation of RAW264.7 macrophages in response to strains
reveals that only the cho1∆/∆ mutant elicits production, and is mediated by the Dectin-1
receptor. The cho1∆/∆ mutant is elevated in TNFα elicitation after an 8 hour incubation, and
this response is reduced to wild type levels when pre-treated with a neutralizing anti-Dectin-1
antibody.
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Figure A5. Stimulation of the High Osmolarity Pathway (HOG) with sorbitol reveals the
cho1∆/∆ mutant is activated differently than wild type. Stimulation reveals that sorbitol
reduces activation of the HOG pathway via a decrease in Hog1p activation, but does not has an
effect on the cell wall integrity pathway (mediated by Mkc1p). Also, this western reveals that the
cell wall integrity pathway is constitutively activate in the cho1∆/∆ mutant. Stimulation was 20
minutes with 1M sorbitol added to YPD.
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Figure A6. Stimulation of the cell wall integrity pathway and Hog1 pathway with
caspofungin. When this pathway was stimulated, it was revealed that the cho1∆/∆ mutant’s
Mkc1p phosphorylation (Mkc2p-P) is constitutively active with or without stimulation, but the
wild-type, cho1∆/∆ reintegrant (cho1::CHO1) or the psd1∆/∆psd2∆/∆ mutants (p1∆/∆p2∆/∆) do
not. Stimulation was 15 minutes with 125 ng caspofungin in YPD media.
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Materials and Methods
Protocols pertaining to Appendix Figures A1, A2, A3 and A4 are described in the materials
method section of Chapter 2.
Western Blot
For both the Hog1p and Mkc1p westerns, the experimental setup were the same. The
day prior to stimulation, 5 mL of YPD were inoculated from plated strains and incubated
overnight at 30°C. The next day, these strains were diluted into flasks with 40 mL of fresh YPD
and grown for 3 hours at 30°C in a shaking incubator.
For the Hog1p western, the cultures were transferred to conicals and pelleted at 3300
rpm for 5 minutes. The pellets were then washed in 15 mL ddH2O and pelleted again. After this,
the pellets were resuspended in 40 mL YPD containing 1mL sorbitol and transferred to new
flasks. These flasks were then incubated in a 30°C shaking incubator for 20 minutes and then
pelleted after stimulation. The pellet was then resuspended in protease and phosphatase
inhibitors (Roche 4906845001) and bead beat and extracted in the same manner as the Rim101
western mentioned in Chapter 3. SDS-PAGE was run with 20 ug protein, and transferred
overnight at 10V. Primary antibodies were anti-P-Mkc1p (Cell Signaling Cat #4370), anti-PHog1p (Cell Signaling Cat# 9216), and anti-tubulin (AbD Serotec, cat# MCA78G). Primary
incubations were performed with antibodies diluted 1:2000 in 5% BSA in TBST and incubated
overnight at 4°C. Membranes were washed 3X quickly with TBST, then another 2X for 5
minutes with TBST. Secondary antibodies conjugated to horseradish peroxidase (HRP) were
then incubated at 1:5000 in 5% with TBST, with anti-rat (for tubulin) (Jackson Immuresearch
Cat#112-035-175), anti-mouse (for P-Hog1p) (Jackson Immunoresearch Cat# 315-035-008),
and anti-rabbit (for P-Mkc1p) (Jackson Immunoresearch Cat# 211-032-171) for 20 minutes at
room temperature. 3 quick washes then 2X 5 minute washes were once again performed in
TBST. Western blot was developed with Supersignal West Pico Chemiluminescent Substrate
(Thermo Scientific cat # 34080).
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For the Mkc1p western, cells were grown to stationary phase overnight in 5mL YPD. The
next day, strains were diluted to a concentration of 0.1 O.D./mL in 40 mL YPD, and incubated at
30°C in a shaking incubator for 3 hours. After this time, cells were stimulated with 125 ng/mL
caspofungin for 10 minutes in a shaking incubator at 30°C (Mitchell 2006). Cells were
centrifuged at 3300 rpm for 5 minutes and pellets were washed in 10 mL PBS. After washing
and re-pelleting, cells were resuspended in 100µL of PBS with 1X protease inhibitor (Roche 04693-124-001) and 1X phosphatase inhibitor (Roche 04-906-001) and transferred to a screwcap
microcentrifuge tube. The cell slurry was then bead beat 3X for 1 minute each time, and then
pelleted at 13000 rpm. Supernatant was then transferred to a new microcentrifuge tube.
Bradford protein assay was performed to ascertain the total protein, then 20 µg of samples
suspended in Laemmli buffer were boiled and then separated on 10% acrylamide gels for 90
minutes at 100 Volts at 4°C, then transferred overnight at 10 Volts at 4°C onto PVDF
membrane. The next day, membranes were blocked for 1 hour in 5% BSA in TBST. Primary
antibodies were anti-P-Mkc1p (Cell Signaling Cat #4370), anti-Mkc1p (Cell Signaling Cat#
9107), anti-P-Hog1p (Cell Signaling Cat# 9216), anti-Hog1p (Santa Cruz Cat# sc-9079), and
anti-tubulin (AbD Serotec, cat# MCA78G). Primary incubations were performed with antibodies
diluted 1:2000 in 5% BSA in TBST and incubated for 90 minutes at 4°C. The membranes were
then quickly washed 3X with TBST, then another 2X for 5 minutes with TBST. Secondary
antibodies conjugated to horseradish peroxidase (HRP) were then incubated at 1:5000 in 5%
with TBST, with anti-rat (for tubulin) (Jackson Immuresearch Cat#112-035-175), anti-mouse (for
P-Hog1p, Hog1p and Mkc1p) (Jackson Immunoresearch Cat# 315-035-008), and anti-rabbit (for
P-Mkc1p) (Jackson Immunoresearch Cat# 211-032-171) for 20 minutes at room temperature. 3
quick washes then 2 5 minute washes were once again performed in TBST. Western blot was
developed with Supersignal West Pico Chemiluminescent Substrate (Thermo Scientific cat #
34080).
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